Page last updated: 2024-10-22

alprazolam and Anxiety Disorders

alprazolam has been researched along with Anxiety Disorders in 257 studies

Alprazolam: A triazolobenzodiazepine compound with antianxiety and sedative-hypnotic actions, that is efficacious in the treatment of PANIC DISORDERS, with or without AGORAPHOBIA, and in generalized ANXIETY DISORDERS. (From AMA Drug Evaluations Annual, 1994, p238)
alprazolam : A member of the class of triazolobenzodiazepines that is 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine carrying methyl, phenyl and chloro substituents at positions 1, 6 and 8 respectively. Alprazolam is only found in individuals that have taken this drug.

Anxiety Disorders: Persistent and disabling ANXIETY.

Research Excerpts

ExcerptRelevanceReference
"Results of this study indicate that panic disorder patients are more vulnerable to alprazolam withdrawal than patients with generalized anxiety disorder, and this may reflect a general diathesis of panic disorder patients to encounter more difficulty during drug withdrawal."9.07Alprazolam withdrawal in patients with panic disorder and generalized anxiety disorder: vulnerability and effect of carbamazepine. ( Colin, V; Klein, E; Lenox, RH; Stolk, J, 1994)
"In a controlled trial of alprazolam and exposure in 154 patients with panic disorder with agoraphobia, relations between panic, anticipatory anxiety, and phobic avoidance were examined."9.07Relationship of panic, anticipatory anxiety, agoraphobia and global improvement in panic disorder with agoraphobia treated with alprazolam and exposure. ( Başoğlu, M; Kiliç, C; Kuch, K; Marks, IM; Noshirvani, H; O'Sullivan, G; Swinson, RP, 1994)
"In a multicenter placebo-controlled study, the safety, side effects, and patient acceptance of alprazolam for the treatment of panic disorder and agoraphobia were examined."9.06Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety. ( Ballenger, JC; Burrows, GD; DuPont, RL; Noyes, R; Pecknold, JC; Rifkin, A; Rubin, RT; Swinson, RP, 1988)
"A case is presented in which, by a double-blind, placebo-controlled trial, alprazolam was shown to produce reversible stuttering."9.05A case report of alprazolam-induced stuttering. ( Elliott, RL; Thomas, BJ, 1985)
"The effect of genetic polymorphism of the CYP3A4 gene on the efficacy and safety profiles of alprazolam was demonstrated in a group of 105 patients with anxiety disorders comorbid with alcohol use disorder."7.96Effects of plasma concentration of micro-RNA Mir-27b and CYP3A4*22 on equilibrium concentration of alprazolam in patients with anxiety disorders comorbid with alcohol use disorder. ( Bryun, EA; Bure, IV; Golovinskii, PA; Grishina, EA; Koporov, SG; Pankratenko, EP; Petukhov, AE; Ryzhikova, KA; Skryabin, VY; Smirnov, VV; Sychev, DA; Zastrozhin, MS; Zastrozhina, AK, 2020)
"Thirty-six patients with panic disorder (PD) and 35 patients with generalized anxiety disorder (GAD) participated in an open alprazolam treatment phase that preceded controlled withdrawal from alprazolam."7.69Clinical similarity and biological diversity in the response to alprazolam in patients with panic disorder and generalized anxiety disorder. ( Colin, V; Greenberg, A; Klein, E; Lenox, RH; Levy, N; Zilberman, I; Zinder, O, 1995)
"A case is reported of delirium and seizures due to the abrupt withdrawal from the benzodiazepine alprazolam."7.67Delirium and seizures due to abrupt alprazolam withdrawal: case report. ( Levy, AB, 1984)
"Seven patients with schizophrenia and panic attacks all showed marked improvement of positive and negative schizophrenic symptoms when alprazolam was openly added to antipsychotic medication."7.67Adjunctive alprazolam for schizophrenia with panic anxiety: clinical observation and pathogenetic implications. ( Kahn, JP; Klein, DF; Puertollano, MA; Schane, MD, 1988)
"Seizures were observed following the withdrawal of alprazolam administered in therapeutic dose for 10 weeks."7.67Seizures following the withdrawal of alprazolam. ( Clancy, J; Coryell, WH; Crowe, RR; Gabel, J; Noyes, R; Perry, PJ; Yamada, T, 1986)
"Clonazepam, a high-potency benzodiazepine marketed for the treatment of minor motor epilepsy, was used to treat 50 patients with panic disorder (N = 22) or agoraphobia with panic attacks (N = 28)."7.67Treatment of panic disorder and agoraphobia with clonazepam. ( Rosenbaum, JF; Spier, SA; Tesar, GE; Woods, SW, 1986)
"Alprazolam therapy was effective and well tolerated at a mean daily dose of 5."6.67Maintenance drug treatment of panic disorder. I. Results of a prospective, placebo-controlled comparison of alprazolam and imipramine. ( Rickels, K; Schweizer, E; Weiss, S; Zavodnick, S, 1993)
"Of 147 cancer patients who met entry levels of distress and completed the study, uncontrolled for site or disease stage, 70 were randomized to drug, 77 to relaxation."6.67A randomized clinical trial of alprazolam versus progressive muscle relaxation in cancer patients with anxiety and depressive symptoms. ( Berenson, S; Breitbart, W; Carpenter, PJ; Derogatis, L; Feldstein, M; Holland, JC; Morrow, GR; Schmale, A; Stefanek, M, 1991)
"Data were drawn from 3 double-blind, randomized, placebo-controlled, published treatment trials: alprazolam for patients with premenstrual syndrome (PMS) and diazepam and lorazepam for patients with generalized anxiety disorder (GAD)."5.09Prior benzodiazepine exposure and benzodiazepine treatment outcome. ( Freeman, EW; Rickels, K, 2000)
"Fifty-two subjects with panic disorder and generalized anxiety disorder were interviewed 12-18 months after they completed an acute treatment study (9-11 weeks) with alprazolam followed by blind and controlled drug discontinuation."5.08Subjective experience and attitudes towards participation in clinical trials among patients with anxiety disorders. ( Klein, E; Lenox, RH; Malel, D; Zilberman, I, 1997)
"6%) of whom had a symptomatic generalized anxiety disorder, were entered into a randomized, double-blind, placebo-controlled, 8-week trial using alprazolam (up to 2 mg/day) as the active agent."5.08Effects of alprazolam on glucose regulation in diabetes. Results of double-blind, placebo-controlled trial. ( Carney, RM; Clouse, RE; Eisen, SA; Freedland, KE; Griffith, LS; Lustman, PJ; McGill, JB; Rubin, EH, 1995)
"The reinforcing effects of alprazolam were investigated in 14 patients who had generalized anxiety or panic disorder, but were not current users/abusers of other psychoactive substances."5.08Alprazolam-reinforced medication use in outpatients with anxiety. ( Creson, DR; Meisch, RA; Roache, JD; Shah, NN; Stanley, MA, 1997)
"In a controlled trial of alprazolam and exposure in 154 patients with panic disorder with agoraphobia, relations between panic, anticipatory anxiety, and phobic avoidance were examined."5.07Relationship of panic, anticipatory anxiety, agoraphobia and global improvement in panic disorder with agoraphobia treated with alprazolam and exposure. ( Başoğlu, M; Kiliç, C; Kuch, K; Marks, IM; Noshirvani, H; O'Sullivan, G; Swinson, RP, 1994)
"Fifty-five young adult patients completed a study comparing alprazolam, propranolol, and placebo in the treatment of panic disorder and agoraphobia with panic attacks."5.07Alprazolam levels and response in panic disorder: preliminary results. ( Munjack, DJ; Palmer, R; Wincor, MZ, 1991)
"Results of this study indicate that panic disorder patients are more vulnerable to alprazolam withdrawal than patients with generalized anxiety disorder, and this may reflect a general diathesis of panic disorder patients to encounter more difficulty during drug withdrawal."5.07Alprazolam withdrawal in patients with panic disorder and generalized anxiety disorder: vulnerability and effect of carbamazepine. ( Colin, V; Klein, E; Lenox, RH; Stolk, J, 1994)
"In a double-blind, placebo-controlled study, the efficacy and safety of alprazolam was investigated in childhood and adolescent anxiety disorders."5.07Clinical, cognitive, and neurophysiological effects of alprazolam in children and adolescents with overanxious and avoidant disorders. ( Dubois, C; Ferguson, HB; Gauthier, B; Knott, V; Roberts, N; Simeon, JG; Wiggins, D, 1992)
"The acute effects of diazepam on plasma GABA were determined in 18 patients with panic disorder, 13 patients with generalized anxiety disorder and 20 healthy controls."5.07Effect of acute and chronic benzodiazepines on plasma GABA in anxious patients and controls. ( Cowley, DS; Greenblatt, DJ; Hommer, D; Kramer, GL; Petty, F; Roy-Byrne, PP, 1992)
"Under a double-blind procedure, 122 patients suffering from general anxiety disorders were randomly allocated to either alpidem (50 mg, three times a day) or alprazolam (0."5.07Comparison of the efficacy, safety and withdrawal of alpidem and alprazolam in anxious patients. ( Albizzati, MG; Bassi, S; Borghi, C; Frattola, L; Garreau, M; Morselli, PL; Piolti, R, 1994)
"In a multicenter placebo-controlled study, the safety, side effects, and patient acceptance of alprazolam for the treatment of panic disorder and agoraphobia were examined."5.06Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety. ( Ballenger, JC; Burrows, GD; DuPont, RL; Noyes, R; Pecknold, JC; Rifkin, A; Rubin, RT; Swinson, RP, 1988)
" A double blind study of alprazolam and placebo in 118 patients with agoraphobia and panic is presented."5.06Psychopharmacological treatment of panic disorder and related states: a placebo controlled study of alprazolam. ( Kuch, K; Pecknold, JC; Swinson, RP, 1987)
" In this non-blind, eight-week trial of alprazolam in patients presenting with chest pain and found to have panic disorder, 15 of 20 met the single criterion for improvement: a 50 percent or greater reduction in panic frequency."5.06Pharmacotherapeutic treatment of panic disorder in patients presenting with chest pain. ( Anderson, S; Basha, IM; Beitman, BD; Flaker, G; Jayaratna, MA; Russell, B; Trombka, LH, 1989)
"An open clinical trial of alprazolam therapy of patients with panic disorder or agoraphobia with panic attacks was undertaken to clarify certain issues not resolved by previous studies."5.06Alprazolam in the treatment of panic disorders. ( Campeas, R; Davies, SR; Fyer, AJ; Goetz, D; Gorman, JM; Klein, DF; Levin, A; Liebowitz, MR, 1986)
"A double-blind study was carried out in 30 female patients with generalized anxiety disorders associated with depressive symptoms to compare the effectiveness and tolerability of etizolam and alprazolam."5.06Etizolam in the treatment of generalized anxiety disorder associated with depressive symptoms. ( Caddeo, S; Ecari, U; Pariante, F, 1989)
"The antipanic efficacy of alprazolam and lorazepam was evaluated in 48 patients meeting DSM-III criteria for agoraphobia with panic attacks or panic disorder in a double-blind random assignment study."5.06Benzodiazepine treatment of panic disorder: a comparison of alprazolam and lorazepam. ( Charney, DS; Woods, SW, 1989)
"A case is presented in which, by a double-blind, placebo-controlled trial, alprazolam was shown to produce reversible stuttering."5.05A case report of alprazolam-induced stuttering. ( Elliott, RL; Thomas, BJ, 1985)
"Alprazolam is a benzodiazepine derivative that is currently used in the treatment of generalized anxiety, panic attacks with or without agoraphobia, and depression."4.82Clinical pharmacology, clinical efficacy, and behavioral toxicity of alprazolam: a review of the literature. ( Verster, JC; Volkerts, ER, 2004)
"A review of the worldwide published literature was conducted to assess the efficacy and safety of alprazolam for the treatment of anxiety disorders, panic disorder, and depression in comparison with those of other active drugs (including other benzodiazepines and antidepressant medications)."4.78A comparison of the safety and efficacy of alprazolam versus other agents in the treatment of anxiety, panic, and depression: a review of the literature. ( Cohon, MS; Jonas, JM, 1993)
" For panic disorder and agoraphobia with panic, the tricyclic antidepressants, the monoamine oxidase inhibitors, and the atypical benzodiazepine alprazolam have proved effective."4.77Pharmacotherapeutic considerations in anxiety disorders. ( Hollister, LE, 1986)
"The effect of genetic polymorphism of the CYP3A4 gene on the efficacy and safety profiles of alprazolam was demonstrated in a group of 105 patients with anxiety disorders comorbid with alcohol use disorder."3.96Effects of plasma concentration of micro-RNA Mir-27b and CYP3A4*22 on equilibrium concentration of alprazolam in patients with anxiety disorders comorbid with alcohol use disorder. ( Bryun, EA; Bure, IV; Golovinskii, PA; Grishina, EA; Koporov, SG; Pankratenko, EP; Petukhov, AE; Ryzhikova, KA; Skryabin, VY; Smirnov, VV; Sychev, DA; Zastrozhin, MS; Zastrozhina, AK, 2020)
"Doctors should closely monitor the severity of alprazolam dependence among long-term users, especially patients' levels of depression, beliefs in the necessity of alprazolam treatment, and their concerns over the adverse consequences of continued treatment with alprazolam."3.81Severity of alprazolam dependence and associated features among long-term alprazolam users from psychiatric outpatient clinics in Taiwan. ( Chen, ST; Chen, TT; Hwang, TJ; Ko, CH; Lin, JJ; Su, PW; Yen, CF; Yen, CN, 2015)
" Clonazepam, with its relatively long half-life, permits less frequent dosing than possible with benzodiazepines with shorter half-lives and more continuous control of anxiety, although around 20% of patients experience unacceptable sedative effects or no reduction in anxiety."3.76High-potency benzodiazepines for short-term management of panic disorder: the U.S. experience. ( Tesar, GE, 1990)
"Alprazolam is a triazolobenzodiazepine which is related to diazepam and other 1,4-benzodiazepines, and has a similar pharmacological profile."3.75Alprazolam: a review of its pharmacodynamic properties and efficacy in the treatment of anxiety and depression. ( Brogden, RN; Dawson, GW; Jue, SG, 1984)
"Thirty-six patients with panic disorder (PD) and 35 patients with generalized anxiety disorder (GAD) participated in an open alprazolam treatment phase that preceded controlled withdrawal from alprazolam."3.69Clinical similarity and biological diversity in the response to alprazolam in patients with panic disorder and generalized anxiety disorder. ( Colin, V; Greenberg, A; Klein, E; Lenox, RH; Levy, N; Zilberman, I; Zinder, O, 1995)
"Seven patients with schizophrenia and panic attacks all showed marked improvement of positive and negative schizophrenic symptoms when alprazolam was openly added to antipsychotic medication."3.67Adjunctive alprazolam for schizophrenia with panic anxiety: clinical observation and pathogenetic implications. ( Kahn, JP; Klein, DF; Puertollano, MA; Schane, MD, 1988)
"Two patients treated with alprazolam for panic disorder and agoraphobia developed a manic episode."3.67Alprazolam-induced manic episode in two patients with panic disorder. ( Fleury, D; Pecknold, JC, 1986)
"Sixty patients with agoraphobia with panic attacks or panic disorder who completed a 4-month combined drug and behavioral group treatment program and were discharged on a regimen of alprazolam were interviewed 1."3.67Clinical and medication outcome after short-term alprazolam and behavioral group treatment in panic disorder. 2.5 year naturalistic follow-up study. ( Charney, DS; Krystal, JH; Nagy, LM; Woods, SW, 1989)
" To assess whether alprazolam alters noradrenergic function, the effects of alprazolam on baseline plasma free 3-methoxy-4-hydroxyphenylethyleneglycol (MHPG), and yohimbine-induced increases in plasma MHPG level, anxiety-nervousness, blood pressure, and somatic symptoms were studied in 14 patients with agoraphobia and panic disorder."3.67Noradrenergic function and the mechanism of action of antianxiety treatment. I. The effect of long-term alprazolam treatment. ( Charney, DS; Heninger, GR, 1985)
"Seizures were observed following the withdrawal of alprazolam administered in therapeutic dose for 10 weeks."3.67Seizures following the withdrawal of alprazolam. ( Clancy, J; Coryell, WH; Crowe, RR; Gabel, J; Noyes, R; Perry, PJ; Yamada, T, 1986)
"Clonazepam, a high-potency benzodiazepine marketed for the treatment of minor motor epilepsy, was used to treat 50 patients with panic disorder (N = 22) or agoraphobia with panic attacks (N = 28)."3.67Treatment of panic disorder and agoraphobia with clonazepam. ( Rosenbaum, JF; Spier, SA; Tesar, GE; Woods, SW, 1986)
"A case is reported of delirium and seizures due to the abrupt withdrawal from the benzodiazepine alprazolam."3.67Delirium and seizures due to abrupt alprazolam withdrawal: case report. ( Levy, AB, 1984)
"Ten cases are presented--two in detail--in which clonazepam was used successfully in patients with treatment-resistant panic disorder with or without agoraphobia."3.67Successful use of clonazepam in patients with treatment-resistant panic disorder. ( Rosenbaum, JF; Tesar, GE, 1986)
" During the second 2 weeks, they all took the same dosage of the extended release formulation."2.69Medication side effects in anxious patients: negative placebo responses? ( Alexander, PE; Coleman, BS; Dempsey, GM; Jones, W; Swiontek, AM; Uhlenhuth, EH, 1998)
" Grapefruit juice altered neither the plasma concentrations of alprazolam at any time points, any pharmacokinetic parameters, nor the majority of psychomotor function parameters in subjects."2.69Effects of repeated ingestion of grapefruit juice on the single and multiple oral-dose pharmacokinetics and pharmacodynamics of alprazolam. ( Furukori, H; Kaneko, S; Kondo, T; Ohkubo, T; Osanai, T; Otani, K; Sugawara, K; Uno, T; Yasui, N, 2000)
"Alprazolam clearly was preferred over placebo; however, there were large between-subjects differences in the amount of medication used."2.69Predictors of individual differences in alprazolam self-medication. ( Oswald, LM; Rhoades, HM; Roache, JD, 1999)
"Alprazolam therapy was effective and well tolerated at a mean daily dose of 5."2.67Maintenance drug treatment of panic disorder. I. Results of a prospective, placebo-controlled comparison of alprazolam and imipramine. ( Rickels, K; Schweizer, E; Weiss, S; Zavodnick, S, 1993)
"Of 147 cancer patients who met entry levels of distress and completed the study, uncontrolled for site or disease stage, 70 were randomized to drug, 77 to relaxation."2.67A randomized clinical trial of alprazolam versus progressive muscle relaxation in cancer patients with anxiety and depressive symptoms. ( Berenson, S; Breitbart, W; Carpenter, PJ; Derogatis, L; Feldstein, M; Holland, JC; Morrow, GR; Schmale, A; Stefanek, M, 1991)
"Sedation and ataxia were the most common side effects reported, but these effects were mild and transient and did not interfere with treatment outcome."2.67Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder. ( Cohen, LS; Herman, JB; Otto, MW; Pollack, MH; Rosenbaum, JF; Sachs, GS; Spier, SA; Tesar, GE, 1991)
"Rebound anxiety and withdrawal symptoms were identified in a substantial minority of patients."2.67Controlled discontinuation of benzodiazepine treatment for patients with panic disorder. ( Cook, B; Garvey, MJ; Noyes, R; Suelzer, M, 1991)
"Alprazolam-treated patients most frequently reported central nervous system-related side effects (drowsiness and sedation), while buspirone-treated patients most frequently reported gastrointestinal system-related side effects (appetite disturbances and abdominal complaints)."2.67Alprazolam versus buspirone in the treatment of outpatients with generalized anxiety disorder. ( Enkelmann, R, 1991)
"Alprazolam was safe, effective, and well tolerated during the acute treatment of comorbid GAD and IBS; only a limited posttreatment rebound was observed."2.67An open label trial of alprazolam in comorbid irritable bowel syndrome and generalized anxiety disorder. ( Dunsmore, G; Luxenberg, M; Tollefson, GD; Tollefson, SL; Valentine, R, 1991)
"The alprazolam effects were apparent by week 1; the imipramine effects by week 4."2.67Cardiovascular and symptomatic reduction effects of alprazolam and imipramine in patients with panic disorder: results of a double-blind, placebo-controlled trial. ( Agras, WS; Clark, D; Ehlers, A; Hayward, C; King, R; Maddock, R; Margraf, J; Roth, WT; Taylor, CB, 1990)
"Desipramine-treated subjects showed gradual improvement over the course of the study, and the improvement in week 1 was not so strongly predictive of overall improvement."2.67Antidepressant or antianxiety? A study of the efficacy of antidepressant medication. ( Edwards, J; Fawcett, J; Fogg, L; Kravitz, HM, 1990)
" A 1 mg dosage increment produced, on the average, a corresponding 10 ng/ml increase in steady state level of the parent drug."2.67The relationship of alprazolam dose to steady-state plasma concentrations. ( Antal, EJ; Ciraulo, DA; Goldberg, DA; Greenblatt, DJ; Olson, DR; Phillips, JP; Rand, EH; Raskin, RB; Shader, RI; Smith, RB, 1990)
"Alprazolam was more effective than imipramine and placebo on anticipatory anxiety and phobic symptoms."2.67Efficacy and safety of alprazolam, imipramine and placebo in treating panic disorder. A Scandinavian multicenter study. ( Andersch, S; Bech, P; Bruun-Hansen, J; Hanson, L; Kullingsjö, H; Lorentzen, K; Mellergård, M; Ottosson, JO; Rasmussen, S; Rosenberg, NK, 1991)
"Buspirone was compared to alprazolam and lorazepam in the treatment of generalized anxiety disorder in a 4-week, double-blind study of 60 patients."2.66Low-sedation potential of buspirone compared with alprazolam and lorazepam in the treatment of anxious patients: a double-blind study. ( Cohn, JB; Wilcox, CS, 1986)
" In a 6-week, double-blind, parallel-design study with flexible dosage scheduling, the authors compared the effects of alprazolam with those of imipramine in 60 patients who had generalized anxiety disorder."2.66Differential effects of alprazolam and imipramine in generalized anxiety disorder: somatic versus psychic symptoms. ( Hoehn-Saric, R; McLeod, DR; Zimmerli, WD, 1988)
"Alprazolam treatment in eight patients markedly attenuated anxiety increases during rebreathing."2.66Carbon dioxide sensitivity in panic anxiety. Ventilatory and anxiogenic response to carbon dioxide in healthy subjects and patients with panic anxiety before and after alprazolam treatment. ( Charney, DS; Goodman, WK; Heninger, GR; Loke, J; Redmond, DE; Woods, SW, 1986)
"Alprazolam was found to be effective and well tolerated."2.66Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment. ( Ballenger, JC; Burrows, GD; DuPont, RL; Lesser, IM; Noyes, R; Pecknold, JC; Rifkin, A; Swinson, RP, 1988)
"Alprazolam was effective in reducing panic and depressive symptomatology in both depressed and nondepressed subjects with panic disorder."2.66Secondary depression in panic disorder and agoraphobia. I. Frequency, severity, and response to treatment. ( Burrows, GD; DuPont, RL; Lesser, IM; Lydiard, RB; Noyes, R; Pecknold, JC; Rifkin, A; Rubin, RT; Swinson, RP, 1988)
"No serious or life-threatening withdrawal symptoms were reported, but distinct, transient, mild to moderate withdrawal syndrome occurred in 35% of the alprazolam-treated group and in none of the placebo-treated group."2.66Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. III. Discontinuation effects. ( Kuch, K; Lewis, CP; Pecknold, JC; Swinson, RP, 1988)
"Alprazolam was as effective as diazepam in the relief of anxiety as measured by the Hamilton Anxiety Rating Scale, Physician's Global Impressions, Patient's Global Impressions, Hopkins Symptom Checklist and Target Symptoms Record."2.65Double-blind comparison of alprazolam and diazepam for subchronic withdrawal from alcohol. ( Kolin, IS; Linet, OI, 1981)
"Alprazolam was more effective than placebo as measured by the Hamilton Anxiety Rating Scale, the Self-Rating Symptom Scale, Target Symptoms, Physician's Global Impressions, and Patient's Global Impressions."2.65Alprazolam in clinically anxious patients with depressed mood. ( Aden, GC, 1983)
"Alprazolam was more effective than placebo on all five measures of efficacy and, on several parameters, more effective than diazepam as well."2.65Anxiolytic efficacy of alprazolam compared to diazepam and placebo. ( Maletzky, BM, 1980)
" Patients were allocated at random to receive alprazolam, in a dosage of 0."2.65Alprazolam in the treatment of neurotic anxiety. ( Kerry, RJ; McDermott, CM, 1983)
"Both alprazolam and diazepam were superior to placebo for the treatment of the clinical anxiety syndrome throughout a four-week double-blind multiclinic trial in 976 outpatients."2.65Multicenter double-blind efficacy and safety study comparing alprazolam, diazepam and placebo in clinically anxious patients. ( Cohn, JB, 1981)
" While their association with sexual dysfunction may be intolerable for some adults, these drugs may be more appropriate than the benzodiazepines because their chronic use does not lead to dependence."2.41Pharmacotherapy of generalized anxiety disorder. ( Rickels, K; Rynn, M, 2002)
" Eighty-two percent (39) of the patients rated clonazepam as being "better" than alprazolam due to decreased dosing frequency and lack of interdose anxiety."2.37Rebound anxiety in panic disorder patients treated with shorter-acting benzodiazepines. ( Brotman, AW; Herman, JB; Rosenbaum, JF, 1987)
" A dose-response effect was evident for PGB that reached a plateau at a dose of 300 mg/d."1.36Comparative efficacy of pregabalin and benzodiazepines in treating the psychic and somatic symptoms of generalized anxiety disorder. ( Feltner, DE; Herman, B; Lydiard, RB; Rickels, K, 2010)
"Psychiatrists treated major depressive disorder in advanced cancer patients on the basis of the algorithm."1.35Clinical experience of the use of a pharmacological treatment algorithm for major depressive disorder in patients with advanced cancer. ( Akechi, T; Akizuki, N; Ito, T; Nakano, T; Okamura, M; Shimizu, K; Uchitomi, Y, 2008)
" Olanzapine (orally disintegrating tablets) in combination with alprazolam was used successfully to relieve this terminally ill patient's anxiety and tension improving his relationship with his physicians and his daily life."1.34Sublingual use of olanzapine in combination with alprazolam to treat agitation in a terminally ill patient receiving parenteral nutrition. ( Douzenis, A; Economopoulos, T; Lykouras, L; Michopoulos, I; Soldatos, CR, 2007)
"In our case of a patient with recurrent major depressive disorder, subthreshold anxiety disorder and addiction to alprazolam, topiramate appears to be efficient and safe in alprazolam withdrawal."1.33Topiramate use in alprazolam addiction. ( Christodoulou, C; Douzenis, A; Lykouras, L; Michopoulos, I, 2006)
"In 2 patients Graves' disease occurred in the setting of previously established euthyroid panic disorder."1.29Graves'disease after the onset of panic disorder. ( Kubo, C; Matsubayashi, S; Matsumoto, Y; Morita, T; Mukuta, T; Tamagawa, K; Tamaí, H, 1996)
" Treatment failures most often result from an inadequate medication trial (ie, trial too brief or dosage inadequate); with adequate treatment most patients with panic disorder can be helped."1.28Panic disorder: diagnosis and treatment. ( O'Boyle, M, 1989)
"All had withdrawal symptoms, six demonstrated tolerance, and at least four had substantial social or occupational impairment secondary to drug use."1.27Alprazolam dependence in seven patients. ( Juergens, SM; Morse, RM, 1988)
"Alprazolam treatment is effective for panic disorder, but its major disadvantages include possible dependence and withdrawal symptoms upon discontinuation."1.27Preliminary evidence for the utility of carbamazepine in alprazolam withdrawal. ( Klein, E; Post, RM; Uhde, TW, 1986)
"Alprazolam treatment led to a complete remission of panic attacks in 85% of the patients; panics ceased within an average of 6 days, at a mean dose of 2."1.27Alprazolam treatment for panic disorders. ( Alexander, DD; Alexander, PE, 1986)
" Subsequent administration of an equivalent dosage of lorazepam did not induce manic symptoms."1.27A case of alprazolam, but not lorazepam, inducing manic symptoms. ( Charney, DS; Goodman, WK, 1987)
"Alprazolam treatment was tapered in 17 panic patients at a rate of 10% of the starting dose every 3 days."1.27Discontinuation of alprazolam treatment in panic patients. ( Campeas, R; Davies, SO; Fyer, AJ; Goetz, D; Gorman, JM; Klein, DF; Levin, A; Liebowitz, MR, 1987)
"Alprazolam is a triazolobenzodiazepine, a derivative of the benzodiazepines."1.26Alprazolam (Xanax, the Upjohn Company). ( Evans, RL, 1981)

Research

Studies (257)

TimeframeStudies, this research(%)All Research%
pre-1990120 (46.69)18.7374
1990's95 (36.96)18.2507
2000's26 (10.12)29.6817
2010's14 (5.45)24.3611
2020's2 (0.78)2.80

Authors

AuthorsStudies
Zastrozhin, MS1
Skryabin, VY1
Smirnov, VV1
Petukhov, AE1
Pankratenko, EP1
Zastrozhina, AK1
Grishina, EA1
Ryzhikova, KA1
Bure, IV1
Golovinskii, PA1
Koporov, SG1
Bryun, EA1
Sychev, DA1
Hassan Basri, M1
Khoo, CS1
Che Hamzah, J1
Romero-Cerecero, O1
Islas-Garduño, AL1
Zamilpa, A1
Herrera-Arellano, A1
Jiménez-Ferrer, E1
Tortoriello, J1
Hlal, H1
Barrimi, M1
Kettani, N1
Rammouz, I1
Aalouane, R1
Poma, SZ1
Merlo-Pich, E1
Bettica, P1
Bani, M1
Fina, P1
Ziviani, L1
Milleri, S1
Chen, TT1
Ko, CH1
Chen, ST1
Yen, CN1
Su, PW1
Hwang, TJ1
Lin, JJ1
Yen, CF1
Siracusa, C1
Stepita, ME1
Türkoğlu, S1
Soria, CA1
Remedi, C1
Núñez, DA1
D'Alessio, L1
Roldán, EJ1
Brown, GG1
Ostrowitzki, S1
Stein, MB1
von Kienlin, M1
Liu, TT1
Simmons, A1
Wierenga, C1
Stein, OY1
Bruns, A1
Bischoff-Grethe, A1
Paulus, M1
Bailey, JE1
Papadopoulos, A1
Seddon, K1
Nutt, DJ1
Feltner, D1
Hill, C1
Lenderking, W1
Williams, V1
Morlock, R1
Lydiard, RB9
Rickels, K8
Herman, B1
Feltner, DE2
Zoberi, K1
Pollard, CA1
García-Gutiérrez, MS1
Manzanares, J1
Petrić, D1
Peitl, MV1
Peitl, V1
Hadley, SJ1
Mandel, FS1
Schweizer, E2
Stahl, SM1
Jaiswal, AK1
Rynn, M1
Möller, HJ2
Klein, E5
Boerner, RJ1
Verster, JC1
Volkerts, ER1
Ibadullaev, ZP1
Pollack, MH6
Zimbroff, DL1
Bielski, RJ1
Tobias, K1
Brock, JD1
Zornberg, GL1
Pande, AC1
Michopoulos, I2
Douzenis, A2
Christodoulou, C1
Lykouras, L2
Lee, SH1
Ahn, SC1
Lee, YJ1
Choi, TK1
Yook, KH1
Suh, SY1
Okamura, M1
Akizuki, N1
Nakano, T1
Shimizu, K1
Ito, T1
Akechi, T1
Uchitomi, Y1
Economopoulos, T1
Soldatos, CR1
Biermann, T1
Bleich, S1
Kornhuber, J1
Hillemacher, T1
Leonard, SK1
Dwyer, JM1
Sukoff Rizzo, SJ1
Platt, B1
Logue, SF1
Neal, SJ1
Malberg, JE1
Beyer, CE1
Schechter, LE1
Rosenzweig-Lipson, S1
Ring, RH1
Barthelmé, B1
Poirot, Y1
Maletzky, BM1
Evans, RL1
Cohn, JB2
Crook, T1
González, ER1
Csanalosi, I1
Greisman, P1
Cohen, D1
Werblowsky, J1
Ross, HA1
Harris, H1
Aden, GC1
Ruiz, AT1
Pies, R1
Claycomb, JB1
Draper, RJ1
Daly, I1
Levy, AB2
Chouinard, G1
Labonte, A1
Fontaine, R1
Annable, L1
Dawson, GW1
Jue, SG1
Brogden, RN1
Kerry, RJ1
McDermott, CM1
Tesar, GE6
Jenike, MA1
Rosenbaum, JF10
Woods, SW7
Groves, JE1
Klerman, GL6
Shehi, M1
Patterson, WM1
Elie, R1
Lamontagne, Y1
Talmud, J1
Straughan, JL1
Robins, AH1
Davis, J1
Bidder, TG1
Ballenger, JC9
Silberman, EK1
Sullivan, JL1
Sheehan, DV7
Van Winter, JT1
Stickler, GB1
Klein, DF6
Molnar, B1
Friedman, MJ1
Stolk, JM1
Harris, PQ1
Cooper, TB1
Kolin, IS1
Linet, OI1
Lustman, PJ1
Griffith, LS1
Clouse, RE1
Freedland, KE1
Eisen, SA1
Rubin, EH1
Carney, RM1
McGill, JB1
Romach, M1
Busto, U1
Somer, G1
Kaplan, HL1
Sellers, E1
Frattola, L1
Garreau, M1
Piolti, R1
Bassi, S1
Albizzati, MG1
Borghi, C1
Morselli, PL1
Steinberg, JR1
Başoğlu, M2
Marks, IM3
Kiliç, C1
Swinson, RP7
Noshirvani, H1
Kuch, K3
O'Sullivan, G1
Jonas, JM2
Piper, A1
Colin, V2
Stolk, J1
Lenox, RH3
Sussman, N1
Owens, MJ1
Vargas, MA1
Nemeroff, CB1
Olanoff, LS1
Greenblatt, DJ4
von Moltke, LL1
Harmatz, JS1
Ciraulo, DA2
Shader, RI2
Cohon, MS1
Barbee, JG1
Weiss, S1
Zavodnick, S1
Fava, GA1
Zinder, O1
Zilberman, I2
Levy, N1
Greenberg, A1
Reddy, J1
Khanna, S1
Anand, U1
Banerjee, A1
Matsubayashi, S1
Tamaí, H1
Matsumoto, Y1
Tamagawa, K1
Mukuta, T1
Morita, T1
Kubo, C1
Raj, AB1
Harnett-Sheehan, K1
Dorotheo, J1
Sheehan, MF1
Trehan, R1
Knapp, E1
Swiontek, A1
Coleman, B1
Roache, JD2
Stanley, MA1
Creson, DR1
Shah, NN1
Meisch, RA1
Freeman, S1
Haida, M1
Itoh, K1
Malel, D1
Uhlenhuth, EH1
Alexander, PE2
Dempsey, GM1
Jones, W1
Coleman, BS1
Swiontek, AM1
Covelli, V1
Maffione, AB1
Nacci, C1
Tatò, E1
Jirillo, E1
Matthews, J1
Scott, EL1
Gelpin, E1
Bonne, O1
Peri, T1
Brandes, D1
Shalev, AY1
Yamada, S2
Yajima, J2
Harano, M1
Miki, K1
Nakamura, J1
Tsuda, A2
Shoji, H1
Maeda, H2
Tanaka, M2
Yamauchi, K1
Oswald, LM1
Rhoades, HM1
Freeman, EW1
Yasui, N1
Kondo, T1
Furukori, H1
Kaneko, S1
Ohkubo, T1
Uno, T1
Osanai, T1
Sugawara, K1
Otani, K1
Volz, HP1
Reimann, IW1
Stoll, KD1
Frémont, P1
Bentué-Ferrer, D1
Reymann, JM1
Tribut, O1
Allain, H1
Vasar, E1
Bourin, M1
Lapierre, YD1
Lauerma, H1
Sandyk, R1
Dann, LC1
Sengün, S1
McCann, UD1
Ricaurte, GA1
Roy-Byrne, PP2
Cowley, DS3
Hommer, D1
Kramer, GL1
Petty, F1
Simeon, JG2
Ferguson, HB2
Knott, V1
Roberts, N1
Gauthier, B1
Dubois, C1
Wiggins, D1
García-Campayo, JJ1
Febrel Bordeje, M1
Campos Ródenas, R1
García Mur, MC1
Glod, CA1
Tollefson, GD2
Luxenberg, M1
Valentine, R1
Dunsmore, G1
Tollefson, SL1
Enkelmann, R1
Buller, R4
Maier, W5
Goldenberg, IM1
Lavori, PW1
Benkert, O2
Rosenberg, R7
Argyle, N2
Roth, M1
Brandon, S1
Andersch, S1
Rosenberg, NK4
Kullingsjö, H1
Ottosson, JO6
Bech, P7
Bruun-Hansen, J2
Hanson, L1
Lorentzen, K2
Mellergård, M7
Rasmussen, S1
Beck, P1
Rimón, R2
Kultalahti, ER1
Kalli, A1
Koskinen, T1
Lepola, U2
Naarala, M1
Tick, E1
Dager, SR3
Avery, DH3
Dunner, DL4
Clark, DB2
Taylor, CB3
Roth, WT3
Hayward, C2
Ehlers, A3
Margraf, J3
Agras, WS3
Burrows, GD8
Norman, TR4
Judd, FK4
Marriott, PF2
Otto, MW2
Sachs, GS3
Herman, JB4
Cohen, LS2
Spier, SA2
Sheikh, J1
Deltito, JA1
Noyes, R11
Garvey, MJ1
Cook, B3
Suelzer, M1
Holland, JC1
Morrow, GR1
Schmale, A1
Derogatis, L1
Stefanek, M1
Berenson, S1
Carpenter, PJ1
Breitbart, W1
Feldstein, M1
Edwards, JG1
Inman, WH1
Pearce, GL1
Rawson, NS1
Wincor, MZ1
Munjack, DJ2
Palmer, R1
Cox, BJ1
Endler, NS1
Melvin, JA1
Crowe, CM1
Laraia, MT4
Fossey, MD1
Zealberg, JJ1
Christie, S1
Bystritsky, A1
Pasnau, RO1
Mattick, RP1
Andrews, G1
Hadzi-Pavlovic, D1
Christensen, H1
Albus, M3
Nutzinger, D1
Shera, D2
King, R1
Maddock, R1
Clark, D1
Kravitz, HM1
Fogg, L1
Fawcett, J1
Edwards, J1
Udelman, HD1
Udelman, DL1
Bernstein, GA1
Garfinkel, BD1
Borchardt, CM1
Nightingale, SL1
O'Neil, C1
Asher, R1
Meltzer-Brody, S1
Davidson, JR1
McLeod, DR4
Hoehn-Saric, R4
Zimmerli, WD3
De Souza, EB1
Oliver, LK1
Khan, A1
Cowley, D1
Elder, J1
Roy-Byrne, P1
Lecrubier, Y1
Hippius, H1
Garvey, M2
Summers, R1
McIntyre, IM1
Armstrong, SM1
Klosko, JS1
Barlow, DH1
Tassinari, R1
Cerny, JA1
Jeffries, JJ1
Risse, SC1
Whitters, A1
Burke, J1
Chen, S1
Scurfield, RM1
Raskind, MA1
Sholomskas, AJ1
Antal, EJ1
Smith, RB1
Olson, DR1
Goldberg, DA1
Rand, EH1
Raskin, RB1
Phillips, JP1
Jolkkonen, J1
Riekkinen, P1
Tollefson, G1
Fishbain, DA1
Sunderland, G1
Friedman, S1
Rosenblum, LA1
Beitman, BD1
Basha, IM1
Trombka, LH1
Jayaratna, MA1
Russell, B1
Flaker, G1
Anderson, S1
De Albuquerque, A1
Cottraux, J1
Gentil, V1
Greist, J1
Hand, I1
Liberman, RL1
Relvas, JS1
Tobeña, A1
Tyrer, P1
Pariante, F1
Caddeo, S1
Ecari, U1
O'Boyle, M1
Hollander, E1
Fairbanks, J1
Decaria, C1
Liebowitz, MR4
Charney, DS8
Pyke, RE2
Nagy, LM1
Krystal, JH1
Söderpalm, B1
Ciccone, PE1
Clancy, J2
Coryell, WH2
Crowe, RR2
Chaudhry, DR1
Domingo, DV1
Heninger, GR6
Elliott, RL1
Thomas, BJ1
Strahan, A1
Rosenthal, J1
Kaswan, M1
Winston, A1
Perry, PJ1
Yamada, T1
Gabel, J1
Pöldinger, W1
Uhde, TW2
Post, RM1
Fyer, AJ2
Gorman, JM2
Campeas, R2
Levin, A2
Davies, SR1
Goetz, D2
Crocker, B1
Carr, DB2
Surman, OS2
Coleman, JH1
Jones, KJ2
Levine, PH1
Watkins, WD1
Newton, RE1
Marunycz, JD1
Alderdice, MT1
Napoliello, MJ1
Pecknold, JC6
Fleury, D1
Scrignar, CB1
Alexander, DD1
Hollister, LE1
Goodman, WK4
Price, LH1
Nesse, RM1
Cameron, OG1
Curtis, GC1
Lee, M1
Sonne, LM1
Wilcox, CS1
Ishiki, D1
Wilson, LG1
Hyde, TS1
Brotman, AW2
Eriksson, E1
Kahn, JP3
Puertollano, MA1
Schane, MD2
Castillo, A1
Sotillo, C1
Mariategui, J1
Reich, J2
Yates, W1
Coryell, W2
Beckett, A1
Fishman, SM2
Loke, J1
Redmond, DE1
Juergens, SM1
Morse, RM1
DuPont, RL3
Lesser, IM2
Rifkin, A3
Rubin, RT2
Lewis, CP1
Dugas, JE1
Mahoney, EM1
McNamara, M1
Goldstein, S2
Soto, S1
Howell, EF3
Kraus, M1
Montague-Clouse, J1
Patterson, JF1
Williams, J1
Strom, TB1
Coleman, J1
Mellman, TA1
Biraghi, M1
Fano, M1
Bernareggi, V1
Rifkin, B1
Kinch, M1
Aiken, B1
Quadrino, LM1
Edlund, MJ1
Swann, AC1
Clothier, J1
Puertollano, M1
Deicken, RF1
Miller, F1
Väisänen, E1
Jalkanen, E1
Sandberg, L1
Siris, SG1
Ries, RK1
Wittkowsky, AK1
O'Gorman, TW1
Stevenson, E1
Topol, P1
Lawlor, BA1
Davies, SO1
Akiskal, HS1

Clinical Trials (5)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Efficacy and Safety Study of a IMSS Developed Phytopharmaceutical for the Treatment of Anxiety. Double Blind and Randomized Clinical Trial Controlled With Alprazolam[NCT03702803]Phase 2122 participants (Anticipated)Interventional2016-03-16Recruiting
The Effectiveness of Psychopharmacological Intervention Versus Cognitive Behavioural Couple Therapy and Their Combination in Perinatal Distressed Couples: A Randomized Clinical Trial[NCT06001021]80 participants (Anticipated)Interventional2023-08-15Not yet recruiting
[NCT00004373]Phase 280 participants Interventional1997-03-31Completed
Early Pharmacological Intervention With Diazepam in the Emergency Room Setting to Prevent Posttraumatic Stress Disorder (PTSD).[NCT01221883]Phase 440 participants (Anticipated)Interventional2013-05-31Active, not recruiting
The Role of Orexin in Human Panic Disorder[NCT02593682]Phase 43 participants (Actual)Interventional2016-05-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

33 reviews available for alprazolam and Anxiety Disorders

ArticleYear
Pharmacotherapy of generalized anxiety disorder.
    The Journal of clinical psychiatry, 2002, Volume: 63 Suppl 14

    Topics: Algorithms; Alprazolam; Antidepressive Agents; Antidepressive Agents, Tricyclic; Anxiety Disorders;

2002
Pharmacotherapy of generalized anxiety disorder.
    The Journal of clinical psychiatry, 2002, Volume: 63 Suppl 14

    Topics: Algorithms; Alprazolam; Antidepressive Agents; Antidepressive Agents, Tricyclic; Anxiety Disorders;

2002
Anxiety associated with comorbid depression.
    The Journal of clinical psychiatry, 2002, Volume: 63 Suppl 14

    Topics: Adult; Algorithms; Alprazolam; Amitriptyline; Antidepressive Agents; Anxiety Disorders; Benzodiazepi

2002
Anxiety associated with comorbid depression.
    The Journal of clinical psychiatry, 2002, Volume: 63 Suppl 14

    Topics: Adult; Algorithms; Alprazolam; Amitriptyline; Antidepressive Agents; Anxiety Disorders; Benzodiazepi

2002
[Panic attacks and panic disorder. Checklist for the diagnosis].
    MMW Fortschritte der Medizin, 2003, May-26, Volume: 145 Suppl 2

    Topics: Adult; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Antidepressive Age

2003
[Panic attacks and panic disorder. Checklist for the diagnosis].
    MMW Fortschritte der Medizin, 2003, May-26, Volume: 145 Suppl 2

    Topics: Adult; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Antidepressive Age

2003
Clinical pharmacology, clinical efficacy, and behavioral toxicity of alprazolam: a review of the literature.
    CNS drug reviews, 2004,Spring, Volume: 10, Issue:1

    Topics: Alprazolam; Animals; Anti-Anxiety Agents; Anxiety Disorders; Automobile Driving; Behavior; Clinical

2004
Clinical pharmacology, clinical efficacy, and behavioral toxicity of alprazolam: a review of the literature.
    CNS drug reviews, 2004,Spring, Volume: 10, Issue:1

    Topics: Alprazolam; Animals; Anti-Anxiety Agents; Anxiety Disorders; Automobile Driving; Behavior; Clinical

2004
Diagnosis and treatment of mixed anxiety-depression in the elderly.
    The Journal of clinical psychiatry, 1982, Volume: 43, Issue:9 Pt 2

    Topics: Adult; Age Factors; Aged; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents; Antidepressive Age

1982
Diagnosis and treatment of mixed anxiety-depression in the elderly.
    The Journal of clinical psychiatry, 1982, Volume: 43, Issue:9 Pt 2

    Topics: Adult; Age Factors; Aged; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents; Antidepressive Age

1982
Alprazolam: a review of its pharmacodynamic properties and efficacy in the treatment of anxiety and depression.
    Drugs, 1984, Volume: 27, Issue:2

    Topics: Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Benzodiazepines;

1984
Alprazolam: a review of its pharmacodynamic properties and efficacy in the treatment of anxiety and depression.
    Drugs, 1984, Volume: 27, Issue:2

    Topics: Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Benzodiazepines;

1984
Psychopharmacology of the anxiety disorders.
    The Psychiatric clinics of North America, 1984, Volume: 7, Issue:4

    Topics: Adrenergic beta-Antagonists; Adult; Agoraphobia; Alprazolam; Antidepressive Agents, Tricyclic; Anxie

1984
Psychopharmacology of the anxiety disorders.
    The Psychiatric clinics of North America, 1984, Volume: 7, Issue:4

    Topics: Adrenergic beta-Antagonists; Adult; Agoraphobia; Alprazolam; Antidepressive Agents, Tricyclic; Anxie

1984
Atypical depression.
    The Psychiatric clinics of North America, 1984, Volume: 7, Issue:3

    Topics: Alprazolam; Anxiety Disorders; Benzodiazepines; Bipolar Disorder; Character; Chronic Disease; Clinic

1984
Atypical depression.
    The Psychiatric clinics of North America, 1984, Volume: 7, Issue:3

    Topics: Alprazolam; Anxiety Disorders; Benzodiazepines; Bipolar Disorder; Character; Chronic Disease; Clinic

1984
Anxiety in elderly patients. A comparison of azapirones and benzodiazepines.
    Drugs & aging, 1994, Volume: 5, Issue:5

    Topics: Aged; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Geriatric Assessment; Humans

1994
Anxiety in elderly patients. A comparison of azapirones and benzodiazepines.
    Drugs & aging, 1994, Volume: 5, Issue:5

    Topics: Aged; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Geriatric Assessment; Humans

1994
Treating anxiety while minimizing abuse and dependence.
    The Journal of clinical psychiatry, 1993, Volume: 54 Suppl

    Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Clorazepate Dipotass

1993
Treating anxiety while minimizing abuse and dependence.
    The Journal of clinical psychiatry, 1993, Volume: 54 Suppl

    Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Clorazepate Dipotass

1993
Alprazolam pharmacokinetics, metabolism, and plasma levels: clinical implications.
    The Journal of clinical psychiatry, 1993, Volume: 54 Suppl

    Topics: Alprazolam; Anxiety Disorders; Biotransformation; Clinical Trials as Topic; Cytochrome P-450 Enzyme

1993
Alprazolam pharmacokinetics, metabolism, and plasma levels: clinical implications.
    The Journal of clinical psychiatry, 1993, Volume: 54 Suppl

    Topics: Alprazolam; Anxiety Disorders; Biotransformation; Clinical Trials as Topic; Cytochrome P-450 Enzyme

1993
A comparison of the safety and efficacy of alprazolam versus other agents in the treatment of anxiety, panic, and depression: a review of the literature.
    The Journal of clinical psychiatry, 1993, Volume: 54 Suppl

    Topics: Alprazolam; Antidepressive Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Clinical Trials as

1993
A comparison of the safety and efficacy of alprazolam versus other agents in the treatment of anxiety, panic, and depression: a review of the literature.
    The Journal of clinical psychiatry, 1993, Volume: 54 Suppl

    Topics: Alprazolam; Antidepressive Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Clinical Trials as

1993
Memory, benzodiazepines, and anxiety: integration of theoretical and clinical perspectives.
    The Journal of clinical psychiatry, 1993, Volume: 54 Suppl

    Topics: Alprazolam; Amnesia; Anxiety Disorders; Benzodiazepines; Dose-Response Relationship, Drug; Humans; M

1993
Memory, benzodiazepines, and anxiety: integration of theoretical and clinical perspectives.
    The Journal of clinical psychiatry, 1993, Volume: 54 Suppl

    Topics: Alprazolam; Amnesia; Anxiety Disorders; Benzodiazepines; Dose-Response Relationship, Drug; Humans; M

1993
Stress, neuropsychiatric disorders and immunological effects exerted by benzodiazepines.
    Immunopharmacology and immunotoxicology, 1998, Volume: 20, Issue:2

    Topics: Adjuvants, Immunologic; Alprazolam; Animals; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines

1998
Stress, neuropsychiatric disorders and immunological effects exerted by benzodiazepines.
    Immunopharmacology and immunotoxicology, 1998, Volume: 20, Issue:2

    Topics: Adjuvants, Immunologic; Alprazolam; Animals; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines

1998
Xanax: pros and cons.
    Journal of psychosocial nursing and mental health services, 1992, Volume: 30, Issue:6

    Topics: Adult; Alprazolam; Anxiety Disorders; Depressive Disorder; Female; Humans; Panic Disorder; Stress Di

1992
Xanax: pros and cons.
    Journal of psychosocial nursing and mental health services, 1992, Volume: 30, Issue:6

    Topics: Adult; Alprazolam; Anxiety Disorders; Depressive Disorder; Female; Humans; Panic Disorder; Stress Di

1992
Validation criteria for panic disorder as a nosological entity.
    Acta psychiatrica Scandinavica. Supplementum, 1991, Volume: 365

    Topics: Alprazolam; Anxiety Disorders; Depressive Disorder; Humans; Imipramine; Panic; Psychiatric Status Ra

1991
Validation criteria for panic disorder as a nosological entity.
    Acta psychiatrica Scandinavica. Supplementum, 1991, Volume: 365

    Topics: Alprazolam; Anxiety Disorders; Depressive Disorder; Humans; Imipramine; Panic; Psychiatric Status Ra

1991
Long-term management of panic disorder.
    The Journal of clinical psychiatry, 1990, Volume: 51 Suppl

    Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Clinical Trials as Topic; Clonazepam; Drug Toler

1990
Long-term management of panic disorder.
    The Journal of clinical psychiatry, 1990, Volume: 51 Suppl

    Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Clinical Trials as Topic; Clonazepam; Drug Toler

1990
High-potency benzodiazepines for short-term management of panic disorder: the U.S. experience.
    The Journal of clinical psychiatry, 1990, Volume: 51 Suppl

    Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Clinical Trials as Topic; Clonazepam; Fear; Huma

1990
High-potency benzodiazepines for short-term management of panic disorder: the U.S. experience.
    The Journal of clinical psychiatry, 1990, Volume: 51 Suppl

    Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Clinical Trials as Topic; Clonazepam; Fear; Huma

1990
Efficacy of benzodiazepines in panic disorder and agoraphobia.
    Journal of psychiatric research, 1990, Volume: 24 Suppl 2

    Topics: Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Arousal; Humans; Panic

1990
Efficacy of benzodiazepines in panic disorder and agoraphobia.
    Journal of psychiatric research, 1990, Volume: 24 Suppl 2

    Topics: Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Arousal; Humans; Panic

1990
Depression and panic anxiety: the effect of depressive co-morbidity on response to drug treatment of patients with panic disorder and agoraphobia.
    Journal of psychiatric research, 1990, Volume: 24 Suppl 2

    Topics: Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Depressive Disorder; Humans; Panic

1990
Depression and panic anxiety: the effect of depressive co-morbidity on response to drug treatment of patients with panic disorder and agoraphobia.
    Journal of psychiatric research, 1990, Volume: 24 Suppl 2

    Topics: Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Depressive Disorder; Humans; Panic

1990
Short-acting versus long-acting benzodiazepines: discontinuation effects in panic disorders.
    Journal of psychiatric research, 1990, Volume: 24 Suppl 2

    Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Diazepam; Drug Administration Schedule; Humans;

1990
Short-acting versus long-acting benzodiazepines: discontinuation effects in panic disorders.
    Journal of psychiatric research, 1990, Volume: 24 Suppl 2

    Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Diazepam; Drug Administration Schedule; Humans;

1990
A review of the psychopharmacology of panic disorder: individual differences and non specific factors.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1991, Volume: 36, Issue:2

    Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Combined Modality Therapy; Humans; Imipramine; Panic; Ph

1991
A review of the psychopharmacology of panic disorder: individual differences and non specific factors.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1991, Volume: 36, Issue:2

    Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Combined Modality Therapy; Humans; Imipramine; Panic; Ph

1991
Panic disorder: a treatment update.
    The Journal of clinical psychiatry, 1991, Volume: 52 Suppl

    Topics: Alprazolam; Antidepressive Agents, Tricyclic; Anxiety Disorders; Benzodiazepines; Humans; Monoamine

1991
Panic disorder: a treatment update.
    The Journal of clinical psychiatry, 1991, Volume: 52 Suppl

    Topics: Alprazolam; Antidepressive Agents, Tricyclic; Anxiety Disorders; Benzodiazepines; Humans; Monoamine

1991
Treatment of panic and agoraphobia. An integrative review.
    The Journal of nervous and mental disease, 1990, Volume: 178, Issue:9

    Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Behavior Therapy; Bibliographies as Topic; Clinical Tria

1990
Treatment of panic and agoraphobia. An integrative review.
    The Journal of nervous and mental disease, 1990, Volume: 178, Issue:9

    Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Behavior Therapy; Bibliographies as Topic; Clinical Tria

1990
Managing long-term therapy for panic disorder.
    The Journal of clinical psychiatry, 1990, Volume: 51 Suppl

    Topics: Alprazolam; Antidepressive Agents, Tricyclic; Anxiety Disorders; Benzodiazepines; Clinical Trials as

1990
Managing long-term therapy for panic disorder.
    The Journal of clinical psychiatry, 1990, Volume: 51 Suppl

    Topics: Alprazolam; Antidepressive Agents, Tricyclic; Anxiety Disorders; Benzodiazepines; Clinical Trials as

1990
Continuation treatment of panic disorder with high-potency benzodiazepines.
    The Journal of clinical psychiatry, 1990, Volume: 51 Suppl A

    Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Behavior Therapy; Benzodiazepines; Clonazepam; Humans; P

1990
Continuation treatment of panic disorder with high-potency benzodiazepines.
    The Journal of clinical psychiatry, 1990, Volume: 51 Suppl A

    Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Behavior Therapy; Benzodiazepines; Clonazepam; Humans; P

1990
Pharmacology of the benzodiazepines; with special emphasis on alprazolam.
    Acta psychiatrica Scandinavica. Supplementum, 1987, Volume: 335

    Topics: Alprazolam; Animals; Anxiety Disorders; Benzodiazepines; Drug Tolerance; Humans; Rats; Receptors, GA

1987
Pharmacology of the benzodiazepines; with special emphasis on alprazolam.
    Acta psychiatrica Scandinavica. Supplementum, 1987, Volume: 335

    Topics: Alprazolam; Animals; Anxiety Disorders; Benzodiazepines; Drug Tolerance; Humans; Rats; Receptors, GA

1987
Monoamine oxidase inhibitors and alprazolam in the treatment of panic disorder and agoraphobia.
    The Psychiatric clinics of North America, 1985, Volume: 8, Issue:1

    Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Cheese; Diet; Drug-Related Side

1985
Monoamine oxidase inhibitors and alprazolam in the treatment of panic disorder and agoraphobia.
    The Psychiatric clinics of North America, 1985, Volume: 8, Issue:1

    Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Cheese; Diet; Drug-Related Side

1985
Generalized anxiety disorder.
    The Psychiatric clinics of North America, 1985, Volume: 8, Issue:1

    Topics: Adrenergic beta-Antagonists; Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents, Tricyc

1985
Generalized anxiety disorder.
    The Psychiatric clinics of North America, 1985, Volume: 8, Issue:1

    Topics: Adrenergic beta-Antagonists; Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents, Tricyc

1985
Review of the side-effect profile of buspirone.
    The American journal of medicine, 1986, Mar-31, Volume: 80, Issue:3B

    Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Clinical Trials as T

1986
Review of the side-effect profile of buspirone.
    The American journal of medicine, 1986, Mar-31, Volume: 80, Issue:3B

    Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Clinical Trials as T

1986
Pharmacotherapeutic considerations in anxiety disorders.
    The Journal of clinical psychiatry, 1986, Volume: 47 Suppl

    Topics: Agoraphobia; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Anxiety Disorders; B

1986
Pharmacotherapeutic considerations in anxiety disorders.
    The Journal of clinical psychiatry, 1986, Volume: 47 Suppl

    Topics: Agoraphobia; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Anxiety Disorders; B

1986
Rebound anxiety in panic disorder patients treated with shorter-acting benzodiazepines.
    The Journal of clinical psychiatry, 1987, Volume: 48 Suppl

    Topics: Acute Disease; Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Clonazepam; Fear; Female;

1987
Rebound anxiety in panic disorder patients treated with shorter-acting benzodiazepines.
    The Journal of clinical psychiatry, 1987, Volume: 48 Suppl

    Topics: Acute Disease; Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Clonazepam; Fear; Female;

1987
Brain neurotransmission in panic disorder.
    Acta psychiatrica Scandinavica. Supplementum, 1987, Volume: 335

    Topics: Alprazolam; Antidepressive Agents; Anxiety Disorders; Brain Chemistry; Fear; Humans; Neurotransmitte

1987
Brain neurotransmission in panic disorder.
    Acta psychiatrica Scandinavica. Supplementum, 1987, Volume: 335

    Topics: Alprazolam; Antidepressive Agents; Anxiety Disorders; Brain Chemistry; Fear; Humans; Neurotransmitte

1987

Trials

113 trials available for alprazolam and Anxiety Disorders

ArticleYear
Galphimine-B Standardized Extract versus Alprazolam in Patients with Generalized Anxiety Disorder: A Ten-Week, Double-Blind, Randomized Clinical Trial.
    BioMed research international, 2019, Volume: 2019

    Topics: Alprazolam; Anxiety Disorders; Double-Blind Method; Female; Galphimia; Humans; Male; Middle Aged; Pa

2019
Galphimine-B Standardized Extract versus Alprazolam in Patients with Generalized Anxiety Disorder: A Ten-Week, Double-Blind, Randomized Clinical Trial.
    BioMed research international, 2019, Volume: 2019

    Topics: Alprazolam; Anxiety Disorders; Double-Blind Method; Female; Galphimia; Humans; Male; Middle Aged; Pa

2019
Anxiolytic effects of vestipitant in a sub-group of healthy volunteers known to be sensitive to CO2 challenge.
    Journal of psychopharmacology (Oxford, England), 2014, Volume: 28, Issue:5

    Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety; Anxiety Disorders; Benzodiazepines; Carbon Dioxide;

2014
Anxiolytic effects of vestipitant in a sub-group of healthy volunteers known to be sensitive to CO2 challenge.
    Journal of psychopharmacology (Oxford, England), 2014, Volume: 28, Issue:5

    Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety; Anxiety Disorders; Benzodiazepines; Carbon Dioxide;

2014
Impact of alprazolam in allostatic load and neurocognition of patients with anxiety disorders and chronic stress (GEMA): observational study protocol.
    BMJ open, 2015, Jul-14, Volume: 5, Issue:7

    Topics: Adult; Aged; Allostasis; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Argentina; Female; Huma

2015
Impact of alprazolam in allostatic load and neurocognition of patients with anxiety disorders and chronic stress (GEMA): observational study protocol.
    BMJ open, 2015, Jul-14, Volume: 5, Issue:7

    Topics: Adult; Aged; Allostasis; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Argentina; Female; Huma

2015
Temporal profile of brain response to alprazolam in patients with generalized anxiety disorder.
    Psychiatry research, 2015, Sep-30, Volume: 233, Issue:3

    Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Brain; Brain Mapping; Double-Blind Method

2015
Temporal profile of brain response to alprazolam in patients with generalized anxiety disorder.
    Psychiatry research, 2015, Sep-30, Volume: 233, Issue:3

    Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Brain; Brain Mapping; Double-Blind Method

2015
A comparison of the effects of a subtype selective and non-selective benzodiazepine receptor agonist in two CO(2) models of experimental human anxiety.
    Journal of psychopharmacology (Oxford, England), 2009, Volume: 23, Issue:2

    Topics: Administration, Inhalation; Adolescent; Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; C

2009
A comparison of the effects of a subtype selective and non-selective benzodiazepine receptor agonist in two CO(2) models of experimental human anxiety.
    Journal of psychopharmacology (Oxford, England), 2009, Volume: 23, Issue:2

    Topics: Administration, Inhalation; Adolescent; Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; C

2009
Development of a patient-reported assessment to identify placebo responders in a generalized anxiety disorder trial.
    Journal of psychiatric research, 2009, Volume: 43, Issue:15

    Topics: Adolescent; Adult; Aged; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Dose-Response Relations

2009
Development of a patient-reported assessment to identify placebo responders in a generalized anxiety disorder trial.
    Journal of psychiatric research, 2009, Volume: 43, Issue:15

    Topics: Adolescent; Adult; Aged; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Dose-Response Relations

2009
Switching from long-term benzodiazepine therapy to pregabalin in patients with generalized anxiety disorder: a double-blind, placebo-controlled trial.
    Journal of psychopharmacology (Oxford, England), 2012, Volume: 26, Issue:4

    Topics: Adult; Alprazolam; Anxiety Disorders; Cognition; Double-Blind Method; Female; gamma-Aminobutyric Aci

2012
Switching from long-term benzodiazepine therapy to pregabalin in patients with generalized anxiety disorder: a double-blind, placebo-controlled trial.
    Journal of psychopharmacology (Oxford, England), 2012, Volume: 26, Issue:4

    Topics: Adult; Alprazolam; Anxiety Disorders; Cognition; Double-Blind Method; Female; gamma-Aminobutyric Aci

2012
[Efficacy of alprazolam (xanax) in mental disorders in patients with left- and right hemispheric ischemic stroke].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2004, Volume: 104, Issue:3

    Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Brain Ischemia; Depressive Disorder; Female; Fun

2004
[Efficacy of alprazolam (xanax) in mental disorders in patients with left- and right hemispheric ischemic stroke].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2004, Volume: 104, Issue:3

    Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Brain Ischemia; Depressive Disorder; Female; Fun

2004
Alprazolam (Xanax, and others) revisited.
    The Medical letter on drugs and therapeutics, 2005, Jan-17, Volume: 47, Issue:1200

    Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Cognitive Behavioral Therapy; Double-Blin

2005
Alprazolam (Xanax, and others) revisited.
    The Medical letter on drugs and therapeutics, 2005, Jan-17, Volume: 47, Issue:1200

    Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Cognitive Behavioral Therapy; Double-Blin

2005
Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam.
    Archives of general psychiatry, 2005, Volume: 62, Issue:9

    Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anticonvulsants; Anxiety Disorders; Dizziness; Double-Blind

2005
Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam.
    Archives of general psychiatry, 2005, Volume: 62, Issue:9

    Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anticonvulsants; Anxiety Disorders; Dizziness; Double-Blind

2005
Effectiveness of a meditation-based stress management program as an adjunct to pharmacotherapy in patients with anxiety disorder.
    Journal of psychosomatic research, 2007, Volume: 62, Issue:2

    Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Combined Modality Therapy; Fluvoxamine; Humans;

2007
Effectiveness of a meditation-based stress management program as an adjunct to pharmacotherapy in patients with anxiety disorder.
    Journal of psychosomatic research, 2007, Volume: 62, Issue:2

    Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Combined Modality Therapy; Fluvoxamine; Humans;

2007
Anxiolytic efficacy of alprazolam compared to diazepam and placebo.
    The Journal of international medical research, 1980, Volume: 8, Issue:2

    Topics: Adolescent; Adult; Aged; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Clinic

1980
Anxiolytic efficacy of alprazolam compared to diazepam and placebo.
    The Journal of international medical research, 1980, Volume: 8, Issue:2

    Topics: Adolescent; Adult; Aged; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Clinic

1980
Multicenter double-blind efficacy and safety study comparing alprazolam, diazepam and placebo in clinically anxious patients.
    The Journal of clinical psychiatry, 1981, Volume: 42, Issue:9

    Topics: Adolescent; Adult; Aged; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Clinic

1981
Multicenter double-blind efficacy and safety study comparing alprazolam, diazepam and placebo in clinically anxious patients.
    The Journal of clinical psychiatry, 1981, Volume: 42, Issue:9

    Topics: Adolescent; Adult; Aged; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Clinic

1981
Recent advances in anxiolytic therapy.
    The Journal of clinical psychiatry, 1981, Volume: 42, Issue:11 Pt 2

    Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Clinical Tria

1981
Recent advances in anxiolytic therapy.
    The Journal of clinical psychiatry, 1981, Volume: 42, Issue:11 Pt 2

    Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Clinical Tria

1981
A controlled clinical trial of alprazolam for the treatment of anxiety.
    The American journal of psychiatry, 1983, Volume: 140, Issue:1

    Topics: Adult; Alprazolam; Ambulatory Care; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Clinica

1983
A controlled clinical trial of alprazolam for the treatment of anxiety.
    The American journal of psychiatry, 1983, Volume: 140, Issue:1

    Topics: Adult; Alprazolam; Ambulatory Care; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Clinica

1983
Alprazolam in clinically anxious patients with depressed mood.
    The Journal of clinical psychiatry, 1983, Volume: 44, Issue:1

    Topics: Adolescent; Adult; Aged; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Depres

1983
Alprazolam in clinically anxious patients with depressed mood.
    The Journal of clinical psychiatry, 1983, Volume: 44, Issue:1

    Topics: Adolescent; Adult; Aged; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Depres

1983
A double-blind study of alprazolam and lorazepam in the treatment of anxiety.
    The Journal of clinical psychiatry, 1983, Volume: 44, Issue:2

    Topics: Adolescent; Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Clinical Tri

1983
A double-blind study of alprazolam and lorazepam in the treatment of anxiety.
    The Journal of clinical psychiatry, 1983, Volume: 44, Issue:2

    Topics: Adolescent; Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Clinical Tri

1983
Alprazolam and amitryptyline: a double blind comparison of anxiolytic and anti-depressant activity.
    Irish medical journal, 1983, Volume: 76, Issue:11

    Topics: Alprazolam; Amitriptyline; Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Benzodiaze

1983
Alprazolam and amitryptyline: a double blind comparison of anxiolytic and anti-depressant activity.
    Irish medical journal, 1983, Volume: 76, Issue:11

    Topics: Alprazolam; Amitriptyline; Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Benzodiaze

1983
New concepts in benzodiazepine therapy: rebound anxiety and new indications for the more potent benzodiazepines.
    Progress in neuro-psychopharmacology & biological psychiatry, 1983, Volume: 7, Issue:4-6

    Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Bipolar Disorder; Bromazepam; C

1983
New concepts in benzodiazepine therapy: rebound anxiety and new indications for the more potent benzodiazepines.
    Progress in neuro-psychopharmacology & biological psychiatry, 1983, Volume: 7, Issue:4-6

    Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Bipolar Disorder; Bromazepam; C

1983
Alprazolam: a review of its pharmacodynamic properties and efficacy in the treatment of anxiety and depression.
    Drugs, 1984, Volume: 27, Issue:2

    Topics: Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Benzodiazepines;

1984
Alprazolam: a review of its pharmacodynamic properties and efficacy in the treatment of anxiety and depression.
    Drugs, 1984, Volume: 27, Issue:2

    Topics: Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Benzodiazepines;

1984
Alprazolam in the treatment of neurotic anxiety.
    Pharmatherapeutica, 1983, Volume: 3, Issue:7

    Topics: Adolescent; Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Clinical Tri

1983
Alprazolam in the treatment of neurotic anxiety.
    Pharmatherapeutica, 1983, Volume: 3, Issue:7

    Topics: Adolescent; Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Clinical Tri

1983
Alprazolam and diazepam in the treatment of generalized anxiety.
    Journal of clinical psychopharmacology, 1984, Volume: 4, Issue:3

    Topics: Adult; Aged; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Clinical Trials as

1984
Alprazolam and diazepam in the treatment of generalized anxiety.
    Journal of clinical psychopharmacology, 1984, Volume: 4, Issue:3

    Topics: Adult; Aged; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Clinical Trials as

1984
Atypical depression.
    The Psychiatric clinics of North America, 1984, Volume: 7, Issue:3

    Topics: Alprazolam; Anxiety Disorders; Benzodiazepines; Bipolar Disorder; Character; Chronic Disease; Clinic

1984
Atypical depression.
    The Psychiatric clinics of North America, 1984, Volume: 7, Issue:3

    Topics: Alprazolam; Anxiety Disorders; Benzodiazepines; Bipolar Disorder; Character; Chronic Disease; Clinic

1984
Double-blind comparison of alprazolam and diazepam for subchronic withdrawal from alcohol.
    The Journal of clinical psychiatry, 1981, Volume: 42, Issue:4

    Topics: Adolescent; Adult; Aged; Alcoholism; Alprazolam; Anxiety Disorders; Benzodiazepines; Clinical Trials

1981
Double-blind comparison of alprazolam and diazepam for subchronic withdrawal from alcohol.
    The Journal of clinical psychiatry, 1981, Volume: 42, Issue:4

    Topics: Adolescent; Adult; Aged; Alcoholism; Alprazolam; Anxiety Disorders; Benzodiazepines; Clinical Trials

1981
Effects of alprazolam on glucose regulation in diabetes. Results of double-blind, placebo-controlled trial.
    Diabetes care, 1995, Volume: 18, Issue:8

    Topics: Adult; Alprazolam; Analysis of Variance; Anti-Anxiety Agents; Anxiety; Anxiety Disorders; Blood Gluc

1995
Effects of alprazolam on glucose regulation in diabetes. Results of double-blind, placebo-controlled trial.
    Diabetes care, 1995, Volume: 18, Issue:8

    Topics: Adult; Alprazolam; Analysis of Variance; Anti-Anxiety Agents; Anxiety; Anxiety Disorders; Blood Gluc

1995
Comparison of the efficacy, safety and withdrawal of alpidem and alprazolam in anxious patients.
    The British journal of psychiatry : the journal of mental science, 1994, Volume: 165, Issue:1

    Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Dose-Response Relationship, Drug; Double-

1994
Comparison of the efficacy, safety and withdrawal of alpidem and alprazolam in anxious patients.
    The British journal of psychiatry : the journal of mental science, 1994, Volume: 165, Issue:1

    Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Dose-Response Relationship, Drug; Double-

1994
Relationship of panic, anticipatory anxiety, agoraphobia and global improvement in panic disorder with agoraphobia treated with alprazolam and exposure.
    The British journal of psychiatry : the journal of mental science, 1994, Volume: 164, Issue:5

    Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Arousal; Combined Modality Therapy; Desensitizati

1994
Relationship of panic, anticipatory anxiety, agoraphobia and global improvement in panic disorder with agoraphobia treated with alprazolam and exposure.
    The British journal of psychiatry : the journal of mental science, 1994, Volume: 164, Issue:5

    Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Arousal; Combined Modality Therapy; Desensitizati

1994
Alprazolam withdrawal in patients with panic disorder and generalized anxiety disorder: vulnerability and effect of carbamazepine.
    The American journal of psychiatry, 1994, Volume: 151, Issue:12

    Topics: Adult; Alprazolam; Anxiety Disorders; Carbamazepine; Double-Blind Method; Drug Administration Schedu

1994
Alprazolam withdrawal in patients with panic disorder and generalized anxiety disorder: vulnerability and effect of carbamazepine.
    The American journal of psychiatry, 1994, Volume: 151, Issue:12

    Topics: Adult; Alprazolam; Anxiety Disorders; Carbamazepine; Double-Blind Method; Drug Administration Schedu

1994
Upjohn answers Consumer Reports.
    Journal of clinical psychopharmacology, 1993, Volume: 13, Issue:5

    Topics: Adverse Drug Reaction Reporting Systems; Alprazolam; Anxiety Disorders; Drug Industry; Humans; Panic

1993
Upjohn answers Consumer Reports.
    Journal of clinical psychopharmacology, 1993, Volume: 13, Issue:5

    Topics: Adverse Drug Reaction Reporting Systems; Alprazolam; Anxiety Disorders; Drug Industry; Humans; Panic

1993
Maintenance drug treatment of panic disorder. I. Results of a prospective, placebo-controlled comparison of alprazolam and imipramine.
    Archives of general psychiatry, 1993, Volume: 50, Issue:1

    Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Dose-Response Relationship, Drug; Double-Blind Me

1993
Maintenance drug treatment of panic disorder. I. Results of a prospective, placebo-controlled comparison of alprazolam and imipramine.
    Archives of general psychiatry, 1993, Volume: 50, Issue:1

    Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Dose-Response Relationship, Drug; Double-Blind Me

1993
Alprazolam-reinforced medication use in outpatients with anxiety.
    Drug and alcohol dependence, 1997, May-02, Volume: 45, Issue:3

    Topics: Adult; Alprazolam; Analysis of Variance; Anti-Anxiety Agents; Anxiety Disorders; Behavior, Addictive

1997
Alprazolam-reinforced medication use in outpatients with anxiety.
    Drug and alcohol dependence, 1997, May-02, Volume: 45, Issue:3

    Topics: Adult; Alprazolam; Analysis of Variance; Anti-Anxiety Agents; Anxiety Disorders; Behavior, Addictive

1997
A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder. Abecarnil Work Group.
    The Journal of clinical psychiatry, 1997, Volume: 58 Suppl 11

    Topics: Adolescent; Adult; Aged; Alprazolam; Ambulatory Care; Anti-Anxiety Agents; Anxiety Disorders; Carbol

1997
A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder. Abecarnil Work Group.
    The Journal of clinical psychiatry, 1997, Volume: 58 Suppl 11

    Topics: Adolescent; Adult; Aged; Alprazolam; Ambulatory Care; Anti-Anxiety Agents; Anxiety Disorders; Carbol

1997
Subjective experience and attitudes towards participation in clinical trials among patients with anxiety disorders.
    The Israel journal of psychiatry and related sciences, 1997, Volume: 34, Issue:4

    Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Female; Humans; Male; Panic Disorder; Pat

1997
Subjective experience and attitudes towards participation in clinical trials among patients with anxiety disorders.
    The Israel journal of psychiatry and related sciences, 1997, Volume: 34, Issue:4

    Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Female; Humans; Male; Panic Disorder; Pat

1997
Medication side effects in anxious patients: negative placebo responses?
    Journal of affective disorders, 1998, Volume: 47, Issue:1-3

    Topics: Acute Disease; Adult; Alprazolam; Anxiety Disorders; Delayed-Action Preparations; Dose-Response Rela

1998
Medication side effects in anxious patients: negative placebo responses?
    Journal of affective disorders, 1998, Volume: 47, Issue:1-3

    Topics: Acute Disease; Adult; Alprazolam; Anxiety Disorders; Delayed-Action Preparations; Dose-Response Rela

1998
Treatment of recent trauma survivors with benzodiazepines: a prospective study.
    The Journal of clinical psychiatry, 1996, Volume: 57, Issue:9

    Topics: Alprazolam; Anxiety Disorders; Arousal; Benzodiazepines; Clonazepam; Follow-Up Studies; Heart Rate;

1996
Treatment of recent trauma survivors with benzodiazepines: a prospective study.
    The Journal of clinical psychiatry, 1996, Volume: 57, Issue:9

    Topics: Alprazolam; Anxiety Disorders; Arousal; Benzodiazepines; Clonazepam; Follow-Up Studies; Heart Rate;

1996
Saliva level of free 3-methoxy-4-hydroxyphenylglycol in psychiatric outpatients with anxiety.
    International clinical psychopharmacology, 1998, Volume: 13, Issue:5

    Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Female; Humans; Male; Methoxyhydroxypheny

1998
Saliva level of free 3-methoxy-4-hydroxyphenylglycol in psychiatric outpatients with anxiety.
    International clinical psychopharmacology, 1998, Volume: 13, Issue:5

    Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Female; Humans; Male; Methoxyhydroxypheny

1998
Predictors of individual differences in alprazolam self-medication.
    Experimental and clinical psychopharmacology, 1999, Volume: 7, Issue:4

    Topics: Adult; Affect; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Double-Blind Method; Female; Huma

1999
Predictors of individual differences in alprazolam self-medication.
    Experimental and clinical psychopharmacology, 1999, Volume: 7, Issue:4

    Topics: Adult; Affect; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Double-Blind Method; Female; Huma

1999
Prior benzodiazepine exposure and benzodiazepine treatment outcome.
    The Journal of clinical psychiatry, 2000, Volume: 61, Issue:6

    Topics: Alprazolam; Anxiety Disorders; Benzodiazepines; Diazepam; Dose-Response Relationship, Drug; Double-B

2000
Prior benzodiazepine exposure and benzodiazepine treatment outcome.
    The Journal of clinical psychiatry, 2000, Volume: 61, Issue:6

    Topics: Alprazolam; Anxiety Disorders; Benzodiazepines; Diazepam; Dose-Response Relationship, Drug; Double-B

2000
Effects of repeated ingestion of grapefruit juice on the single and multiple oral-dose pharmacokinetics and pharmacodynamics of alprazolam.
    Psychopharmacology, 2000, Volume: 150, Issue:2

    Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Beverages; Citrus; Cross-Over Studies; Cy

2000
Effects of repeated ingestion of grapefruit juice on the single and multiple oral-dose pharmacokinetics and pharmacodynamics of alprazolam.
    Psychopharmacology, 2000, Volume: 150, Issue:2

    Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Beverages; Citrus; Cross-Over Studies; Cy

2000
Opipramol for the treatment of generalized anxiety disorder: a placebo-controlled trial including an alprazolam-treated group.
    Journal of clinical psychopharmacology, 2001, Volume: 21, Issue:1

    Topics: Adolescent; Adult; Aged; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Anxiety

2001
Opipramol for the treatment of generalized anxiety disorder: a placebo-controlled trial including an alprazolam-treated group.
    Journal of clinical psychopharmacology, 2001, Volume: 21, Issue:1

    Topics: Adolescent; Adult; Aged; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Anxiety

2001
Drug treatment of panic disorder. Reply to comment by Marks and associates.
    The British journal of psychiatry : the journal of mental science, 1992, Volume: 161

    Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Cross-Cultural Comparison; Dose-Response Relationship, D

1992
Drug treatment of panic disorder. Reply to comment by Marks and associates.
    The British journal of psychiatry : the journal of mental science, 1992, Volume: 161

    Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Cross-Cultural Comparison; Dose-Response Relationship, D

1992
Effect of acute and chronic benzodiazepines on plasma GABA in anxious patients and controls.
    Psychopharmacology, 1992, Volume: 109, Issue:1-2

    Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Diazepam; gamma-Aminobutyric Acid; Humans

1992
Effect of acute and chronic benzodiazepines on plasma GABA in anxious patients and controls.
    Psychopharmacology, 1992, Volume: 109, Issue:1-2

    Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Diazepam; gamma-Aminobutyric Acid; Humans

1992
Clinical, cognitive, and neurophysiological effects of alprazolam in children and adolescents with overanxious and avoidant disorders.
    Journal of the American Academy of Child and Adolescent Psychiatry, 1992, Volume: 31, Issue:1

    Topics: Adolescent; Alprazolam; Anxiety Disorders; Arousal; Cerebral Cortex; Child; Double-Blind Method; Ele

1992
Clinical, cognitive, and neurophysiological effects of alprazolam in children and adolescents with overanxious and avoidant disorders.
    Journal of the American Academy of Child and Adolescent Psychiatry, 1992, Volume: 31, Issue:1

    Topics: Adolescent; Alprazolam; Anxiety Disorders; Arousal; Cerebral Cortex; Child; Double-Blind Method; Ele

1992
An open label trial of alprazolam in comorbid irritable bowel syndrome and generalized anxiety disorder.
    The Journal of clinical psychiatry, 1991, Volume: 52, Issue:12

    Topics: Alprazolam; Anxiety Disorders; Colonic Diseases, Functional; Comorbidity; Female; Humans; Male; Midd

1991
An open label trial of alprazolam in comorbid irritable bowel syndrome and generalized anxiety disorder.
    The Journal of clinical psychiatry, 1991, Volume: 52, Issue:12

    Topics: Alprazolam; Anxiety Disorders; Colonic Diseases, Functional; Comorbidity; Female; Humans; Male; Midd

1991
Alprazolam versus buspirone in the treatment of outpatients with generalized anxiety disorder.
    Psychopharmacology, 1991, Volume: 105, Issue:3

    Topics: Adolescent; Adult; Aged; Alprazolam; Anxiety Disorders; Buspirone; Double-Blind Method; Female; Huma

1991
Alprazolam versus buspirone in the treatment of outpatients with generalized anxiety disorder.
    Psychopharmacology, 1991, Volume: 105, Issue:3

    Topics: Adolescent; Adult; Aged; Alprazolam; Anxiety Disorders; Buspirone; Double-Blind Method; Female; Huma

1991
Chronology of panic and avoidance, age of onset in panic disorder, and prediction of treatment response. A report from the Cross-National Collaborative Panic Study.
    European archives of psychiatry and clinical neuroscience, 1991, Volume: 240, Issue:3

    Topics: Adult; Age Factors; Alprazolam; Anxiety Disorders; Arousal; Drug Administration Schedule; Female; Hu

1991
Chronology of panic and avoidance, age of onset in panic disorder, and prediction of treatment response. A report from the Cross-National Collaborative Panic Study.
    European archives of psychiatry and clinical neuroscience, 1991, Volume: 240, Issue:3

    Topics: Adult; Age Factors; Alprazolam; Anxiety Disorders; Arousal; Drug Administration Schedule; Female; Hu

1991
Subtyping panic disorder by major depression and avoidance behaviour and the response to active treatment.
    European archives of psychiatry and clinical neuroscience, 1991, Volume: 241, Issue:1

    Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Depressive Disorder; Double-Blind Method; Female;

1991
Subtyping panic disorder by major depression and avoidance behaviour and the response to active treatment.
    European archives of psychiatry and clinical neuroscience, 1991, Volume: 241, Issue:1

    Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Depressive Disorder; Double-Blind Method; Female;

1991
Efficacy and safety of alprazolam, imipramine and placebo in treating panic disorder. A Scandinavian multicenter study.
    Acta psychiatrica Scandinavica. Supplementum, 1991, Volume: 365

    Topics: Adolescent; Adult; Alprazolam; Anxiety Disorders; Arousal; Child; Double-Blind Method; Female; Human

1991
Efficacy and safety of alprazolam, imipramine and placebo in treating panic disorder. A Scandinavian multicenter study.
    Acta psychiatrica Scandinavica. Supplementum, 1991, Volume: 365

    Topics: Adolescent; Adult; Alprazolam; Anxiety Disorders; Arousal; Child; Double-Blind Method; Female; Human

1991
A trend analysis of changes during treatment of panic disorder with alprazolam and imipramine.
    Acta psychiatrica Scandinavica. Supplementum, 1991, Volume: 365

    Topics: Alprazolam; Anxiety Disorders; Arousal; Humans; Imipramine; Panic; Personality Tests; Psychiatric St

1991
A trend analysis of changes during treatment of panic disorder with alprazolam and imipramine.
    Acta psychiatrica Scandinavica. Supplementum, 1991, Volume: 365

    Topics: Alprazolam; Anxiety Disorders; Arousal; Humans; Imipramine; Panic; Personality Tests; Psychiatric St

1991
Characteristics of panic disorder patients responding to placebo.
    Acta psychiatrica Scandinavica. Supplementum, 1991, Volume: 365

    Topics: Alprazolam; Anxiety Disorders; Double-Blind Method; Drug Evaluation; Female; Humans; Imipramine; Mal

1991
Characteristics of panic disorder patients responding to placebo.
    Acta psychiatrica Scandinavica. Supplementum, 1991, Volume: 365

    Topics: Alprazolam; Anxiety Disorders; Double-Blind Method; Drug Evaluation; Female; Humans; Imipramine; Mal

1991
Secondary depression in panic disorder: an indicator of severity with a weak effect on outcome in alprazolam and imipramine treatment.
    Acta psychiatrica Scandinavica. Supplementum, 1991, Volume: 365

    Topics: Alprazolam; Anxiety Disorders; Depressive Disorder; Double-Blind Method; Follow-Up Studies; Humans;

1991
Secondary depression in panic disorder: an indicator of severity with a weak effect on outcome in alprazolam and imipramine treatment.
    Acta psychiatrica Scandinavica. Supplementum, 1991, Volume: 365

    Topics: Alprazolam; Anxiety Disorders; Depressive Disorder; Double-Blind Method; Follow-Up Studies; Humans;

1991
Alprazolam, imipramine and placebo treatment of panic disorder: predicting therapeutic response.
    Acta psychiatrica Scandinavica. Supplementum, 1991, Volume: 365

    Topics: Adult; Alprazolam; Anxiety Disorders; Double-Blind Method; Female; Follow-Up Studies; Humans; Imipra

1991
Alprazolam, imipramine and placebo treatment of panic disorder: predicting therapeutic response.
    Acta psychiatrica Scandinavica. Supplementum, 1991, Volume: 365

    Topics: Adult; Alprazolam; Anxiety Disorders; Double-Blind Method; Female; Follow-Up Studies; Humans; Imipra

1991
Alprazolam and oxazepam in the treatment of anxious out-patients with depressive symptoms: a double-blind multicenter study.
    Pharmacopsychiatry, 1991, Volume: 24, Issue:3

    Topics: Adult; Alprazolam; Anxiety Disorders; Depression; Double-Blind Method; Humans; Middle Aged; Oxazepam

1991
Alprazolam and oxazepam in the treatment of anxious out-patients with depressive symptoms: a double-blind multicenter study.
    Pharmacopsychiatry, 1991, Volume: 24, Issue:3

    Topics: Adult; Alprazolam; Anxiety Disorders; Depression; Double-Blind Method; Humans; Middle Aged; Oxazepam

1991
Lactate vulnerability after alprazolam versus placebo treatment of panic disorder.
    Biological psychiatry, 1991, Jul-01, Volume: 30, Issue:1

    Topics: Adult; Alprazolam; Anxiety Disorders; Arousal; Depressive Disorder; Dose-Response Relationship, Drug

1991
Lactate vulnerability after alprazolam versus placebo treatment of panic disorder.
    Biological psychiatry, 1991, Jul-01, Volume: 30, Issue:1

    Topics: Adult; Alprazolam; Anxiety Disorders; Arousal; Depressive Disorder; Dose-Response Relationship, Drug

1991
Surreptitious drug use by patients in a panic disorder study.
    The American journal of psychiatry, 1990, Volume: 147, Issue:4

    Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Clinical Trials as Topic; Double-Blind Me

1990
Surreptitious drug use by patients in a panic disorder study.
    The American journal of psychiatry, 1990, Volume: 147, Issue:4

    Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Clinical Trials as Topic; Double-Blind Me

1990
Long-term management of panic disorder.
    The Journal of clinical psychiatry, 1990, Volume: 51 Suppl

    Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Clinical Trials as Topic; Clonazepam; Drug Toler

1990
Long-term management of panic disorder.
    The Journal of clinical psychiatry, 1990, Volume: 51 Suppl

    Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Clinical Trials as Topic; Clonazepam; Drug Toler

1990
High-potency benzodiazepines for short-term management of panic disorder: the U.S. experience.
    The Journal of clinical psychiatry, 1990, Volume: 51 Suppl

    Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Clinical Trials as Topic; Clonazepam; Fear; Huma

1990
High-potency benzodiazepines for short-term management of panic disorder: the U.S. experience.
    The Journal of clinical psychiatry, 1990, Volume: 51 Suppl

    Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Clinical Trials as Topic; Clonazepam; Fear; Huma

1990
Efficacy of benzodiazepines in panic disorder and agoraphobia.
    Journal of psychiatric research, 1990, Volume: 24 Suppl 2

    Topics: Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Arousal; Humans; Panic

1990
Efficacy of benzodiazepines in panic disorder and agoraphobia.
    Journal of psychiatric research, 1990, Volume: 24 Suppl 2

    Topics: Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Arousal; Humans; Panic

1990
Depression and panic anxiety: the effect of depressive co-morbidity on response to drug treatment of patients with panic disorder and agoraphobia.
    Journal of psychiatric research, 1990, Volume: 24 Suppl 2

    Topics: Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Depressive Disorder; Humans; Panic

1990
Depression and panic anxiety: the effect of depressive co-morbidity on response to drug treatment of patients with panic disorder and agoraphobia.
    Journal of psychiatric research, 1990, Volume: 24 Suppl 2

    Topics: Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Depressive Disorder; Humans; Panic

1990
Short-acting versus long-acting benzodiazepines: discontinuation effects in panic disorders.
    Journal of psychiatric research, 1990, Volume: 24 Suppl 2

    Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Diazepam; Drug Administration Schedule; Humans;

1990
Short-acting versus long-acting benzodiazepines: discontinuation effects in panic disorders.
    Journal of psychiatric research, 1990, Volume: 24 Suppl 2

    Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Diazepam; Drug Administration Schedule; Humans;

1990
Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder.
    The Journal of clinical psychiatry, 1991, Volume: 52, Issue:2

    Topics: Adult; Alprazolam; Anxiety Disorders; Ataxia; Clonazepam; Double-Blind Method; Female; Humans; Male;

1991
Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder.
    The Journal of clinical psychiatry, 1991, Volume: 52, Issue:2

    Topics: Adult; Alprazolam; Anxiety Disorders; Ataxia; Clonazepam; Double-Blind Method; Female; Humans; Male;

1991
How "blind" are double-blind studies?
    Journal of consulting and clinical psychology, 1991, Volume: 59, Issue:1

    Topics: Adult; Alprazolam; Anxiety Disorders; Double-Blind Method; Female; Humans; Imipramine; Male; Middle

1991
How "blind" are double-blind studies?
    Journal of consulting and clinical psychology, 1991, Volume: 59, Issue:1

    Topics: Adult; Alprazolam; Anxiety Disorders; Double-Blind Method; Female; Humans; Imipramine; Male; Middle

1991
Patients with panic disorder unaccompanied by depression improve with alprazolam and imipramine treatment.
    The Journal of clinical psychiatry, 1991, Volume: 52, Issue:3

    Topics: Adult; Alprazolam; Anxiety Disorders; Comorbidity; Depressive Disorder; Double-Blind Method; Female;

1991
Patients with panic disorder unaccompanied by depression improve with alprazolam and imipramine treatment.
    The Journal of clinical psychiatry, 1991, Volume: 52, Issue:3

    Topics: Adult; Alprazolam; Anxiety Disorders; Comorbidity; Depressive Disorder; Double-Blind Method; Female;

1991
Controlled discontinuation of benzodiazepine treatment for patients with panic disorder.
    The American journal of psychiatry, 1991, Volume: 148, Issue:4

    Topics: Adult; Alprazolam; Anxiety Disorders; Diazepam; Double-Blind Method; Female; Half-Life; Humans; Male

1991
Controlled discontinuation of benzodiazepine treatment for patients with panic disorder.
    The American journal of psychiatry, 1991, Volume: 148, Issue:4

    Topics: Adult; Alprazolam; Anxiety Disorders; Diazepam; Double-Blind Method; Female; Half-Life; Humans; Male

1991
A randomized clinical trial of alprazolam versus progressive muscle relaxation in cancer patients with anxiety and depressive symptoms.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1991, Volume: 9, Issue:6

    Topics: Adult; Aged; Alprazolam; Anxiety Disorders; Behavior Therapy; Depression; Female; Humans; Male; Midd

1991
A randomized clinical trial of alprazolam versus progressive muscle relaxation in cancer patients with anxiety and depressive symptoms.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1991, Volume: 9, Issue:6

    Topics: Adult; Aged; Alprazolam; Anxiety Disorders; Behavior Therapy; Depression; Female; Humans; Male; Midd

1991
Alprazolam levels and response in panic disorder: preliminary results.
    Journal of clinical psychopharmacology, 1991, Volume: 11, Issue:1

    Topics: Adolescent; Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Chromatography, Gas; Female; Humans;

1991
Alprazolam levels and response in panic disorder: preliminary results.
    Journal of clinical psychopharmacology, 1991, Volume: 11, Issue:1

    Topics: Adolescent; Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Chromatography, Gas; Female; Humans;

1991
Effect of alprazolam on depression in panic disorder.
    Journal of clinical psychopharmacology, 1991, Volume: 11, Issue:2

    Topics: Adolescent; Adult; Aged; Alprazolam; Anxiety Disorders; Depressive Disorder; Dose-Response Relations

1991
Effect of alprazolam on depression in panic disorder.
    Journal of clinical psychopharmacology, 1991, Volume: 11, Issue:2

    Topics: Adolescent; Adult; Aged; Alprazolam; Anxiety Disorders; Depressive Disorder; Dose-Response Relations

1991
Treatment of panic and agoraphobia. An integrative review.
    The Journal of nervous and mental disease, 1990, Volume: 178, Issue:9

    Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Behavior Therapy; Bibliographies as Topic; Clinical Tria

1990
Treatment of panic and agoraphobia. An integrative review.
    The Journal of nervous and mental disease, 1990, Volume: 178, Issue:9

    Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Behavior Therapy; Bibliographies as Topic; Clinical Tria

1990
Self- and observer assessment in anxiolytic drug trials: a comparison of their validity.
    European archives of psychiatry and clinical neuroscience, 1990, Volume: 240, Issue:2

    Topics: Adult; Alprazolam; Anxiety Disorders; Double-Blind Method; Humans; Imipramine; Middle Aged; Panic; P

1990
Self- and observer assessment in anxiolytic drug trials: a comparison of their validity.
    European archives of psychiatry and clinical neuroscience, 1990, Volume: 240, Issue:2

    Topics: Adult; Alprazolam; Anxiety Disorders; Double-Blind Method; Humans; Imipramine; Middle Aged; Panic; P

1990
Consistencies and discrepancies in self- and observer-rated anxiety scales. A comparison between the self- and observer-rated Marks-Sheehan scales.
    European archives of psychiatry and clinical neuroscience, 1990, Volume: 240, Issue:2

    Topics: Adult; Alprazolam; Anxiety Disorders; Double-Blind Method; Humans; Imipramine; Middle Aged; Panic; P

1990
Consistencies and discrepancies in self- and observer-rated anxiety scales. A comparison between the self- and observer-rated Marks-Sheehan scales.
    European archives of psychiatry and clinical neuroscience, 1990, Volume: 240, Issue:2

    Topics: Adult; Alprazolam; Anxiety Disorders; Double-Blind Method; Humans; Imipramine; Middle Aged; Panic; P

1990
Cardiovascular and symptomatic reduction effects of alprazolam and imipramine in patients with panic disorder: results of a double-blind, placebo-controlled trial.
    Journal of clinical psychopharmacology, 1990, Volume: 10, Issue:2

    Topics: Adult; Agoraphobia; Alprazolam; Analysis of Variance; Anxiety; Anxiety Disorders; Depression; Disabi

1990
Cardiovascular and symptomatic reduction effects of alprazolam and imipramine in patients with panic disorder: results of a double-blind, placebo-controlled trial.
    Journal of clinical psychopharmacology, 1990, Volume: 10, Issue:2

    Topics: Adult; Agoraphobia; Alprazolam; Analysis of Variance; Anxiety; Anxiety Disorders; Depression; Disabi

1990
Patterns of response during placebo treatment of panic disorder.
    Acta psychiatrica Scandinavica, 1990, Volume: 81, Issue:4

    Topics: Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Double-Blind Method; Fear; Follow-Up Studie

1990
Patterns of response during placebo treatment of panic disorder.
    Acta psychiatrica Scandinavica, 1990, Volume: 81, Issue:4

    Topics: Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Double-Blind Method; Fear; Follow-Up Studie

1990
Antidepressant or antianxiety? A study of the efficacy of antidepressant medication.
    Psychiatry research, 1990, Volume: 32, Issue:2

    Topics: Adult; Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Depressive Disorder; Desipramine; Dr

1990
Antidepressant or antianxiety? A study of the efficacy of antidepressant medication.
    Psychiatry research, 1990, Volume: 32, Issue:2

    Topics: Adult; Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Depressive Disorder; Desipramine; Dr

1990
Concurrent use of buspirone in anxious patients during withdrawal from alprazolam therapy.
    The Journal of clinical psychiatry, 1990, Volume: 51 Suppl

    Topics: Adolescent; Adult; Aged; Alprazolam; Anxiety Disorders; Buspirone; Double-Blind Method; Drug Adminis

1990
Concurrent use of buspirone in anxious patients during withdrawal from alprazolam therapy.
    The Journal of clinical psychiatry, 1990, Volume: 51 Suppl

    Topics: Adolescent; Adult; Aged; Alprazolam; Anxiety Disorders; Buspirone; Double-Blind Method; Drug Adminis

1990
Comparative studies of pharmacotherapy for school refusal.
    Journal of the American Academy of Child and Adolescent Psychiatry, 1990, Volume: 29, Issue:5

    Topics: Adjustment Disorders; Adolescent; Alprazolam; Anxiety Disorders; Child; Depressive Disorder; Double-

1990
Comparative studies of pharmacotherapy for school refusal.
    Journal of the American Academy of Child and Adolescent Psychiatry, 1990, Volume: 29, Issue:5

    Topics: Adjustment Disorders; Adolescent; Alprazolam; Anxiety Disorders; Child; Depressive Disorder; Double-

1990
Characteristics of placebo response during long-term treatment of panic disorder.
    Psychopharmacology bulletin, 1990, Volume: 26, Issue:3

    Topics: Adult; Alprazolam; Anxiety Disorders; Double-Blind Method; Female; Humans; Longitudinal Studies; Mal

1990
Characteristics of placebo response during long-term treatment of panic disorder.
    Psychopharmacology bulletin, 1990, Volume: 26, Issue:3

    Topics: Adult; Alprazolam; Anxiety Disorders; Double-Blind Method; Female; Humans; Longitudinal Studies; Mal

1990
Drug treatment of panic disorder: early response to treatment as a predictor of final outcome.
    Acta psychiatrica Scandinavica, 1990, Volume: 82, Issue:5

    Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Arousal; Double-Blind Method; Female; Humans; Imi

1990
Drug treatment of panic disorder: early response to treatment as a predictor of final outcome.
    Acta psychiatrica Scandinavica, 1990, Volume: 82, Issue:5

    Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Arousal; Double-Blind Method; Female; Humans; Imi

1990
A comparison of alprazolam and behavior therapy in treatment of panic disorder.
    Journal of consulting and clinical psychology, 1990, Volume: 58, Issue:1

    Topics: Adolescent; Adult; Aged; Alprazolam; Analysis of Variance; Anxiety Disorders; Behavior Therapy; Chi-

1990
A comparison of alprazolam and behavior therapy in treatment of panic disorder.
    Journal of consulting and clinical psychology, 1990, Volume: 58, Issue:1

    Topics: Adolescent; Adult; Aged; Alprazolam; Analysis of Variance; Anxiety Disorders; Behavior Therapy; Chi-

1990
The relationship of alprazolam dose to steady-state plasma concentrations.
    Journal of clinical psychopharmacology, 1990, Volume: 10, Issue:1

    Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Dose-Response Relations

1990
The relationship of alprazolam dose to steady-state plasma concentrations.
    Journal of clinical psychopharmacology, 1990, Volume: 10, Issue:1

    Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Dose-Response Relations

1990
Long-term effects of alprazolam and imipramine on cerebrospinal fluid monoamine metabolites and neuropeptides in panic disorder.
    Neuropsychobiology, 1989, Volume: 21, Issue:4

    Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; beta-Endorphin; Clinical Trials as Topic; Double-

1989
Long-term effects of alprazolam and imipramine on cerebrospinal fluid monoamine metabolites and neuropeptides in panic disorder.
    Neuropsychobiology, 1989, Volume: 21, Issue:4

    Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; beta-Endorphin; Clinical Trials as Topic; Double-

1989
Pharmacotherapeutic treatment of panic disorder in patients presenting with chest pain.
    The Journal of family practice, 1989, Volume: 28, Issue:2

    Topics: Adult; Alprazolam; Anxiety Disorders; Chest Pain; Clinical Trials as Topic; Fear; Female; Humans; Ma

1989
Pharmacotherapeutic treatment of panic disorder in patients presenting with chest pain.
    The Journal of family practice, 1989, Volume: 28, Issue:2

    Topics: Adult; Alprazolam; Anxiety Disorders; Chest Pain; Clinical Trials as Topic; Fear; Female; Humans; Ma

1989
The 'efficacy' of alprazolam in panic disorder and agoraphobia: a critique of recent reports.
    Archives of general psychiatry, 1989, Volume: 46, Issue:7

    Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Double-Blind Method; Fear; Hum

1989
The 'efficacy' of alprazolam in panic disorder and agoraphobia: a critique of recent reports.
    Archives of general psychiatry, 1989, Volume: 46, Issue:7

    Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Double-Blind Method; Fear; Hum

1989
Etizolam in the treatment of generalized anxiety disorder associated with depressive symptoms.
    Current medical research and opinion, 1989, Volume: 11, Issue:9

    Topics: Adult; Alprazolam; Anxiety Disorders; Consumer Behavior; Depression; Diazepam; Double-Blind Method;

1989
Etizolam in the treatment of generalized anxiety disorder associated with depressive symptoms.
    Current medical research and opinion, 1989, Volume: 11, Issue:9

    Topics: Adult; Alprazolam; Anxiety Disorders; Consumer Behavior; Depression; Diazepam; Double-Blind Method;

1989
Benzodiazepine treatment of panic disorder: a comparison of alprazolam and lorazepam.
    The Journal of clinical psychiatry, 1989, Volume: 50, Issue:11

    Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Double-Blind Method; Fear; Humans; Lorazepam; Panic; Ran

1989
Benzodiazepine treatment of panic disorder: a comparison of alprazolam and lorazepam.
    The Journal of clinical psychiatry, 1989, Volume: 50, Issue:11

    Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Double-Blind Method; Fear; Humans; Lorazepam; Panic; Ran

1989
A case report of alprazolam-induced stuttering.
    Journal of clinical psychopharmacology, 1985, Volume: 5, Issue:3

    Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Depressive Disorder; Dos

1985
A case report of alprazolam-induced stuttering.
    Journal of clinical psychopharmacology, 1985, Volume: 5, Issue:3

    Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Depressive Disorder; Dos

1985
[Alprazolam vs. oxazepam in the treatment of anxious-neurotic patients].
    Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1985, Oct-29, Volume: 74, Issue:44

    Topics: Adult; Aged; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Clinical Trials as

1985
[Alprazolam vs. oxazepam in the treatment of anxious-neurotic patients].
    Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1985, Oct-29, Volume: 74, Issue:44

    Topics: Adult; Aged; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Clinical Trials as

1985
Alprazolam in the treatment of panic disorders.
    Journal of clinical psychopharmacology, 1986, Volume: 6, Issue:1

    Topics: Adult; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Clinical Tr

1986
Alprazolam in the treatment of panic disorders.
    Journal of clinical psychopharmacology, 1986, Volume: 6, Issue:1

    Topics: Adult; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Clinical Tr

1986
Neuroendocrine correlates of lactate-induced anxiety and their response to chronic alprazolam therapy.
    The American journal of psychiatry, 1986, Volume: 143, Issue:4

    Topics: Adolescent; Adult; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines;

1986
Neuroendocrine correlates of lactate-induced anxiety and their response to chronic alprazolam therapy.
    The American journal of psychiatry, 1986, Volume: 143, Issue:4

    Topics: Adolescent; Adult; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines;

1986
Review of the side-effect profile of buspirone.
    The American journal of medicine, 1986, Mar-31, Volume: 80, Issue:3B

    Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Clinical Trials as T

1986
Review of the side-effect profile of buspirone.
    The American journal of medicine, 1986, Mar-31, Volume: 80, Issue:3B

    Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Clinical Trials as T

1986
Ineffectiveness of clonidine in the treatment of the benzodiazepine withdrawal syndrome: report of three cases.
    The American journal of psychiatry, 1986, Volume: 143, Issue:7

    Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Blood Pressure; Clinical

1986
Ineffectiveness of clonidine in the treatment of the benzodiazepine withdrawal syndrome: report of three cases.
    The American journal of psychiatry, 1986, Volume: 143, Issue:7

    Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Blood Pressure; Clinical

1986
[Alprazolam (Tafil) and bromazepam (Lexotan) in the treatment of anxiety. A randomized, double-blind comparison in psychiatric outpatients].
    Ugeskrift for laeger, 1986, Jun-02, Volume: 148, Issue:23

    Topics: Adolescent; Adult; Aged; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Bromaz

1986
[Alprazolam (Tafil) and bromazepam (Lexotan) in the treatment of anxiety. A randomized, double-blind comparison in psychiatric outpatients].
    Ugeskrift for laeger, 1986, Jun-02, Volume: 148, Issue:23

    Topics: Adolescent; Adult; Aged; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Bromaz

1986
Low-sedation potential of buspirone compared with alprazolam and lorazepam in the treatment of anxious patients: a double-blind study.
    The Journal of clinical psychiatry, 1986, Volume: 47, Issue:8

    Topics: Adolescent; Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; C

1986
Low-sedation potential of buspirone compared with alprazolam and lorazepam in the treatment of anxious patients: a double-blind study.
    The Journal of clinical psychiatry, 1986, Volume: 47, Issue:8

    Topics: Adolescent; Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; C

1986
Effect of alprazolam and diazepam on anxiety and panic attacks in panic disorder: a controlled study.
    The Journal of clinical psychiatry, 1986, Volume: 47, Issue:9

    Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Clinical Trials as Topic

1986
Effect of alprazolam and diazepam on anxiety and panic attacks in panic disorder: a controlled study.
    The Journal of clinical psychiatry, 1986, Volume: 47, Issue:9

    Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Clinical Trials as Topic

1986
Alprazolam compared to clobazam and placebo in anxious outpatients.
    Neuropsychobiology, 1987, Volume: 18, Issue:4

    Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Benzodiazepinones; Clini

1987
Alprazolam compared to clobazam and placebo in anxious outpatients.
    Neuropsychobiology, 1987, Volume: 18, Issue:4

    Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Benzodiazepinones; Clini

1987
Differential effects of alprazolam and imipramine in generalized anxiety disorder: somatic versus psychic symptoms.
    The Journal of clinical psychiatry, 1988, Volume: 49, Issue:8

    Topics: Adult; Alprazolam; Analysis of Variance; Anxiety Disorders; Clinical Trials as Topic; Double-Blind M

1988
Differential effects of alprazolam and imipramine in generalized anxiety disorder: somatic versus psychic symptoms.
    The Journal of clinical psychiatry, 1988, Volume: 49, Issue:8

    Topics: Adult; Alprazolam; Analysis of Variance; Anxiety Disorders; Clinical Trials as Topic; Double-Blind M

1988
Placebo response in panic disorder.
    The American journal of psychiatry, 1988, Volume: 145, Issue:9

    Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Dexamethasone; Diazepam

1988
Placebo response in panic disorder.
    The American journal of psychiatry, 1988, Volume: 145, Issue:9

    Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Dexamethasone; Diazepam

1988
Carbon dioxide sensitivity in panic anxiety. Ventilatory and anxiogenic response to carbon dioxide in healthy subjects and patients with panic anxiety before and after alprazolam treatment.
    Archives of general psychiatry, 1986, Volume: 43, Issue:9

    Topics: Adult; Alprazolam; Anxiety Disorders; Benzodiazepines; Brain; Carbon Dioxide; Chemoreceptor Cells; F

1986
Carbon dioxide sensitivity in panic anxiety. Ventilatory and anxiogenic response to carbon dioxide in healthy subjects and patients with panic anxiety before and after alprazolam treatment.
    Archives of general psychiatry, 1986, Volume: 43, Issue:9

    Topics: Adult; Alprazolam; Anxiety Disorders; Benzodiazepines; Brain; Carbon Dioxide; Chemoreceptor Cells; F

1986
Overview of the Cross-National Collaborative Panic Study.
    Archives of general psychiatry, 1988, Volume: 45, Issue:5

    Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Fear; Goals; Humans; Imipramin

1988
Overview of the Cross-National Collaborative Panic Study.
    Archives of general psychiatry, 1988, Volume: 45, Issue:5

    Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Fear; Goals; Humans; Imipramin

1988
Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment.
    Archives of general psychiatry, 1988, Volume: 45, Issue:5

    Topics: Adolescent; Adult; Aged; Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Double-Blind Metho

1988
Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment.
    Archives of general psychiatry, 1988, Volume: 45, Issue:5

    Topics: Adolescent; Adult; Aged; Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Double-Blind Metho

1988
Secondary depression in panic disorder and agoraphobia. I. Frequency, severity, and response to treatment.
    Archives of general psychiatry, 1988, Volume: 45, Issue:5

    Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Depressive Disorder; Do

1988
Secondary depression in panic disorder and agoraphobia. I. Frequency, severity, and response to treatment.
    Archives of general psychiatry, 1988, Volume: 45, Issue:5

    Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Depressive Disorder; Do

1988
Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. III. Discontinuation effects.
    Archives of general psychiatry, 1988, Volume: 45, Issue:5

    Topics: Adult; Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Drug Administration Schedule; Fear;

1988
Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. III. Discontinuation effects.
    Archives of general psychiatry, 1988, Volume: 45, Issue:5

    Topics: Adult; Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Drug Administration Schedule; Fear;

1988
Misrepresenting uncontrolled clinical observations as "research".
    The Journal of clinical psychiatry, 1987, Volume: 48, Issue:7

    Topics: Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Fear; Humans; Panic; Research Design; Retro

1987
Misrepresenting uncontrolled clinical observations as "research".
    The Journal of clinical psychiatry, 1987, Volume: 48, Issue:7

    Topics: Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Fear; Humans; Panic; Research Design; Retro

1987
Clonazepam versus alprazolam in the treatment of panic disorder: interim analysis of data from a prospective, double-blind, placebo-controlled trial.
    The Journal of clinical psychiatry, 1987, Volume: 48 Suppl

    Topics: Adolescent; Adult; Aged; Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Clonazepam; Double

1987
Clonazepam versus alprazolam in the treatment of panic disorder: interim analysis of data from a prospective, double-blind, placebo-controlled trial.
    The Journal of clinical psychiatry, 1987, Volume: 48 Suppl

    Topics: Adolescent; Adult; Aged; Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Clonazepam; Double

1987
Recent developments in the treatment of panic disorder.
    Acta psychiatrica Scandinavica. Supplementum, 1987, Volume: 335

    Topics: Alprazolam; Antidepressive Agents; Anxiety Disorders; Behavior Therapy; Benzodiazepines; Clinical Tr

1987
Recent developments in the treatment of panic disorder.
    Acta psychiatrica Scandinavica. Supplementum, 1987, Volume: 335

    Topics: Alprazolam; Antidepressive Agents; Anxiety Disorders; Behavior Therapy; Benzodiazepines; Clinical Tr

1987
Alprazolam effects in children with anxiety disorders.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1987, Volume: 32, Issue:7

    Topics: Adolescent; Alprazolam; Anxiety Disorders; Child; Clinical Trials as Topic; Female; Humans; Male; Ps

1987
Alprazolam effects in children with anxiety disorders.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1987, Volume: 32, Issue:7

    Topics: Adolescent; Alprazolam; Anxiety Disorders; Child; Clinical Trials as Topic; Female; Humans; Male; Ps

1987
Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety.
    Archives of general psychiatry, 1988, Volume: 45, Issue:5

    Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Ataxia; Chemical and Drug Induced Liver Injury; F

1988
Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety.
    Archives of general psychiatry, 1988, Volume: 45, Issue:5

    Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Ataxia; Chemical and Drug Induced Liver Injury; F

1988
Immunological response to stress in agoraphobia and panic attacks.
    Biological psychiatry, 1986, Volume: 21, Issue:8-9

    Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Benzodiazepines; Clinical Trials as Topic; Fear;

1986
Immunological response to stress in agoraphobia and panic attacks.
    Biological psychiatry, 1986, Volume: 21, Issue:8-9

    Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Benzodiazepines; Clinical Trials as Topic; Fear;

1986
Withdrawal syndrome with gradual tapering of alprazolam.
    The American journal of psychiatry, 1986, Volume: 143, Issue:11

    Topics: Adult; Alprazolam; Anxiety Disorders; Bipolar Disorder; Clinical Trials as Topic; Double-Blind Metho

1986
Withdrawal syndrome with gradual tapering of alprazolam.
    The American journal of psychiatry, 1986, Volume: 143, Issue:11

    Topics: Adult; Alprazolam; Anxiety Disorders; Bipolar Disorder; Clinical Trials as Topic; Double-Blind Metho

1986
[Multicenter clinical experimentation with alprazolam].
    La Clinica terapeutica, 1986, Sep-30, Volume: 118, Issue:6

    Topics: Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Depression; Female; Humans; Male; Panic

1986
[Multicenter clinical experimentation with alprazolam].
    La Clinica terapeutica, 1986, Sep-30, Volume: 118, Issue:6

    Topics: Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Depression; Female; Humans; Male; Panic

1986
Drug treatment of panic disorder: the comparative efficacy of imipramine, alprazolam, and trazodone.
    The Journal of clinical psychiatry, 1986, Volume: 47, Issue:12

    Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Fear; Humans; Imipramine; Pani

1986
Drug treatment of panic disorder: the comparative efficacy of imipramine, alprazolam, and trazodone.
    The Journal of clinical psychiatry, 1986, Volume: 47, Issue:12

    Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Fear; Humans; Imipramine; Pani

1986
A double-blind study of alprazolam and oxazepam in the treatment of anxiety.
    Acta psychiatrica Scandinavica, 1987, Volume: 75, Issue:5

    Topics: Adult; Alprazolam; Anxiety Disorders; Depression; Double-Blind Method; Female; Humans; Male; Middle

1987
A double-blind study of alprazolam and oxazepam in the treatment of anxiety.
    Acta psychiatrica Scandinavica, 1987, Volume: 75, Issue:5

    Topics: Adult; Alprazolam; Anxiety Disorders; Depression; Double-Blind Method; Female; Humans; Male; Middle

1987
Psychopharmacological treatment of panic disorder and related states: a placebo controlled study of alprazolam.
    Progress in neuro-psychopharmacology & biological psychiatry, 1987, Volume: 11, Issue:2-3

    Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Dose-Response Relationship, Drug; Fear; Humans; Panic; P

1987
Psychopharmacological treatment of panic disorder and related states: a placebo controlled study of alprazolam.
    Progress in neuro-psychopharmacology & biological psychiatry, 1987, Volume: 11, Issue:2-3

    Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Dose-Response Relationship, Drug; Fear; Humans; Panic; P

1987
Serotonin function in panic disorders. The effect of intravenous tryptophan in healthy subjects and patients with panic disorder before and during alprazolam treatment.
    Archives of general psychiatry, 1986, Volume: 43, Issue:11

    Topics: Adult; Alprazolam; Anxiety Disorders; Fear; Female; Humans; Male; Panic; Prolactin; Secretory Rate;

1986
Serotonin function in panic disorders. The effect of intravenous tryptophan in healthy subjects and patients with panic disorder before and during alprazolam treatment.
    Archives of general psychiatry, 1986, Volume: 43, Issue:11

    Topics: Adult; Alprazolam; Anxiety Disorders; Fear; Female; Humans; Male; Panic; Prolactin; Secretory Rate;

1986

Other Studies

120 other studies available for alprazolam and Anxiety Disorders

ArticleYear
Effects of plasma concentration of micro-RNA Mir-27b and CYP3A4*22 on equilibrium concentration of alprazolam in patients with anxiety disorders comorbid with alcohol use disorder.
    Gene, 2020, May-20, Volume: 739

    Topics: Adult; Alcoholism; Alprazolam; Anxiety Disorders; Biomarkers; Biotransformation; Comorbidity; Cytoch

2020
Effects of plasma concentration of micro-RNA Mir-27b and CYP3A4*22 on equilibrium concentration of alprazolam in patients with anxiety disorders comorbid with alcohol use disorder.
    Gene, 2020, May-20, Volume: 739

    Topics: Adult; Alcoholism; Alprazolam; Anxiety Disorders; Biomarkers; Biotransformation; Comorbidity; Cytoch

2020
Dilated pupils in an anxious patient.
    Acta neurologica Belgica, 2021, Volume: 121, Issue:2

    Topics: Alprazolam; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Anxiety Disorders; Citalo

2021
Dilated pupils in an anxious patient.
    Acta neurologica Belgica, 2021, Volume: 121, Issue:2

    Topics: Alprazolam; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Anxiety Disorders; Citalo

2021
["Factitious disorder and skin picking: Clinical approach". A case report].
    L'Encephale, 2014, Volume: 40, Issue:2

    Topics: Alprazolam; Anxiety Disorders; Comorbidity; Diagnosis, Differential; Disruptive, Impulse Control, an

2014
["Factitious disorder and skin picking: Clinical approach". A case report].
    L'Encephale, 2014, Volume: 40, Issue:2

    Topics: Alprazolam; Anxiety Disorders; Comorbidity; Diagnosis, Differential; Disruptive, Impulse Control, an

2014
Severity of alprazolam dependence and associated features among long-term alprazolam users from psychiatric outpatient clinics in Taiwan.
    Journal of the Formosan Medical Association = Taiwan yi zhi, 2015, Volume: 114, Issue:11

    Topics: Adult; Alprazolam; Ambulatory Care Facilities; Anti-Anxiety Agents; Anxiety Disorders; Comorbidity;

2015
Severity of alprazolam dependence and associated features among long-term alprazolam users from psychiatric outpatient clinics in Taiwan.
    Journal of the Formosan Medical Association = Taiwan yi zhi, 2015, Volume: 114, Issue:11

    Topics: Adult; Alprazolam; Ambulatory Care Facilities; Anti-Anxiety Agents; Anxiety Disorders; Comorbidity;

2015
Animal behavior case of the month. Excessive fear of the unfamiliar in a dog.
    Journal of the American Veterinary Medical Association, 2014, Jun-01, Volume: 244, Issue:11

    Topics: Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Behavior, Animal

2014
Animal behavior case of the month. Excessive fear of the unfamiliar in a dog.
    Journal of the American Veterinary Medical Association, 2014, Jun-01, Volume: 244, Issue:11

    Topics: Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Behavior, Animal

2014
Animal behavior case of the month. Fear-related aggression.
    Journal of the American Veterinary Medical Association, 2014, Aug-15, Volume: 245, Issue:4

    Topics: Aggression; Alprazolam; Animals; Anti-Anxiety Agents; Anxiety Disorders; Behavior, Animal; Dogs; Fea

2014
Animal behavior case of the month. Fear-related aggression.
    Journal of the American Veterinary Medical Association, 2014, Aug-15, Volume: 245, Issue:4

    Topics: Aggression; Alprazolam; Animals; Anti-Anxiety Agents; Anxiety Disorders; Behavior, Animal; Dogs; Fea

2014
Paradoxical reactions related to alprazolam.
    Journal of child and adolescent psychopharmacology, 2015, Volume: 25, Issue:3

    Topics: Adolescent; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Humans; Male; Self-Injurious Behavio

2015
Paradoxical reactions related to alprazolam.
    Journal of child and adolescent psychopharmacology, 2015, Volume: 25, Issue:3

    Topics: Adolescent; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Humans; Male; Self-Injurious Behavio

2015
Comparative efficacy of pregabalin and benzodiazepines in treating the psychic and somatic symptoms of generalized anxiety disorder.
    The international journal of neuropsychopharmacology, 2010, Volume: 13, Issue:2

    Topics: Adolescent; Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Dose-Response Relationship, D

2010
Comparative efficacy of pregabalin and benzodiazepines in treating the psychic and somatic symptoms of generalized anxiety disorder.
    The international journal of neuropsychopharmacology, 2010, Volume: 13, Issue:2

    Topics: Adolescent; Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Dose-Response Relationship, D

2010
Treating anxiety without SSRIs.
    The Journal of family practice, 2010, Volume: 59, Issue:3

    Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anticonvulsants; Anxiety Disorders; Benzodiazepines; Comorbi

2010
Treating anxiety without SSRIs.
    The Journal of family practice, 2010, Volume: 59, Issue:3

    Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anticonvulsants; Anxiety Disorders; Benzodiazepines; Comorbi

2010
Overexpression of CB2 cannabinoid receptors decreased vulnerability to anxiety and impaired anxiolytic action of alprazolam in mice.
    Journal of psychopharmacology (Oxford, England), 2011, Volume: 25, Issue:1

    Topics: Alprazolam; Amygdala; Animals; Anti-Anxiety Agents; Anxiety; Anxiety Disorders; Gene Expression; Hip

2011
Overexpression of CB2 cannabinoid receptors decreased vulnerability to anxiety and impaired anxiolytic action of alprazolam in mice.
    Journal of psychopharmacology (Oxford, England), 2011, Volume: 25, Issue:1

    Topics: Alprazolam; Amygdala; Animals; Anti-Anxiety Agents; Anxiety; Anxiety Disorders; Gene Expression; Hip

2011
High doses alprazolam induced amenorrhoea and galactorrhoea.
    Psychiatria Danubina, 2011, Volume: 23, Issue:1

    Topics: Adult; Alprazolam; Amenorrhea; Anti-Anxiety Agents; Anxiety Disorders; Delayed-Action Preparations;

2011
High doses alprazolam induced amenorrhoea and galactorrhoea.
    Psychiatria Danubina, 2011, Volume: 23, Issue:1

    Topics: Adult; Alprazolam; Amenorrhea; Anti-Anxiety Agents; Anxiety Disorders; Delayed-Action Preparations;

2011
Don't ask, don't tell, but benzodiazepines are still the leading treatments for anxiety disorder.
    The Journal of clinical psychiatry, 2002, Volume: 63, Issue:9

    Topics: Alprazolam; Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Drug Therapy, Combination

2002
Don't ask, don't tell, but benzodiazepines are still the leading treatments for anxiety disorder.
    The Journal of clinical psychiatry, 2002, Volume: 63, Issue:9

    Topics: Alprazolam; Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Drug Therapy, Combination

2002
Effect of prenatal alprazolam exposure on anxiety patterns in rat offspring.
    Indian journal of experimental biology, 2002, Volume: 40, Issue:1

    Topics: Alprazolam; Animals; Anti-Anxiety Agents; Anxiety Disorders; Behavior, Animal; Exploratory Behavior;

2002
Effect of prenatal alprazolam exposure on anxiety patterns in rat offspring.
    Indian journal of experimental biology, 2002, Volume: 40, Issue:1

    Topics: Alprazolam; Animals; Anti-Anxiety Agents; Anxiety Disorders; Behavior, Animal; Exploratory Behavior;

2002
The role of extended-release benzodiazepines in the treatment of anxiety: a risk-benefit evaluation with a focus on extended-release alprazolam.
    The Journal of clinical psychiatry, 2002, Volume: 63 Suppl 14

    Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Clinical Trials as Topic; Delay

2002
The role of extended-release benzodiazepines in the treatment of anxiety: a risk-benefit evaluation with a focus on extended-release alprazolam.
    The Journal of clinical psychiatry, 2002, Volume: 63 Suppl 14

    Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Clinical Trials as Topic; Delay

2002
New drug and dosage form.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2005, Jun-01, Volume: 62, Issue:11

    Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Drug Approval; Exenatide; Humans; Hypoglycemic A

2005
New drug and dosage form.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2005, Jun-01, Volume: 62, Issue:11

    Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Drug Approval; Exenatide; Humans; Hypoglycemic A

2005
Topiramate use in alprazolam addiction.
    The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2006, Volume: 7, Issue:4

    Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anticonvulsants; Antidepressive Agents, Second-Generation; A

2006
Topiramate use in alprazolam addiction.
    The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2006, Volume: 7, Issue:4

    Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anticonvulsants; Antidepressive Agents, Second-Generation; A

2006
Clinical experience of the use of a pharmacological treatment algorithm for major depressive disorder in patients with advanced cancer.
    Psycho-oncology, 2008, Volume: 17, Issue:2

    Topics: Adult; Aged; Algorithms; Alprazolam; Amitriptyline; Antidepressive Agents; Anxiety Disorders; Benzod

2008
Clinical experience of the use of a pharmacological treatment algorithm for major depressive disorder in patients with advanced cancer.
    Psycho-oncology, 2008, Volume: 17, Issue:2

    Topics: Adult; Aged; Algorithms; Alprazolam; Amitriptyline; Antidepressive Agents; Anxiety Disorders; Benzod

2008
Sublingual use of olanzapine in combination with alprazolam to treat agitation in a terminally ill patient receiving parenteral nutrition.
    European journal of cancer care, 2007, Volume: 16, Issue:3

    Topics: Administration, Sublingual; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Hum

2007
Sublingual use of olanzapine in combination with alprazolam to treat agitation in a terminally ill patient receiving parenteral nutrition.
    European journal of cancer care, 2007, Volume: 16, Issue:3

    Topics: Administration, Sublingual; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Hum

2007
Pregabalin in benzodiazepine withdrawal.
    Pharmacopsychiatry, 2007, Volume: 40, Issue:6

    Topics: Adult; Alprazolam; Anticonvulsants; Anxiety Disorders; gamma-Aminobutyric Acid; Humans; Hypnotics an

2007
Pregabalin in benzodiazepine withdrawal.
    Pharmacopsychiatry, 2007, Volume: 40, Issue:6

    Topics: Adult; Alprazolam; Anticonvulsants; Anxiety Disorders; gamma-Aminobutyric Acid; Humans; Hypnotics an

2007
Pharmacology of neuropeptide S in mice: therapeutic relevance to anxiety disorders.
    Psychopharmacology, 2008, Volume: 197, Issue:4

    Topics: Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Anxiety Disorders; Arousal

2008
Pharmacology of neuropeptide S in mice: therapeutic relevance to anxiety disorders.
    Psychopharmacology, 2008, Volume: 197, Issue:4

    Topics: Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Anxiety Disorders; Arousal

2008
[Anxiety level and addiction to first-time prescriptions of anxiolytics: a psychometric study].
    Presse medicale (Paris, France : 1983), 2008, Volume: 37, Issue:11

    Topics: Adult; Aged; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Bromazepam; Cardio

2008
[Anxiety level and addiction to first-time prescriptions of anxiolytics: a psychometric study].
    Presse medicale (Paris, France : 1983), 2008, Volume: 37, Issue:11

    Topics: Adult; Aged; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Bromazepam; Cardio

2008
Alprazolam (Xanax, the Upjohn Company).
    Drug intelligence & clinical pharmacy, 1981, Volume: 15, Issue:9

    Topics: Adjustment Disorders; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Depressiv

1981
Alprazolam (Xanax, the Upjohn Company).
    Drug intelligence & clinical pharmacy, 1981, Volume: 15, Issue:9

    Topics: Adjustment Disorders; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Depressiv

1981
Alprazolam (Xanax).
    The Medical letter on drugs and therapeutics, 1982, Apr-16, Volume: 24, Issue:607

    Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Depressive Disorder; Humans

1982
Alprazolam (Xanax).
    The Medical letter on drugs and therapeutics, 1982, Apr-16, Volume: 24, Issue:607

    Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Depressive Disorder; Humans

1982
Panic disorder may respond to new 'antidepressants'.
    JAMA, 1982, Dec-17, Volume: 248, Issue:23

    Topics: Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Fear; Female; Huma

1982
Panic disorder may respond to new 'antidepressants'.
    JAMA, 1982, Dec-17, Volume: 248, Issue:23

    Topics: Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Fear; Female; Huma

1982
Alprazolam for panic disorder and depression.
    The American journal of psychiatry, 1983, Volume: 140, Issue:5

    Topics: Adolescent; Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Depressive D

1983
Alprazolam for panic disorder and depression.
    The American journal of psychiatry, 1983, Volume: 140, Issue:5

    Topics: Adolescent; Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Depressive D

1983
Endogenous anxiety: implications for nosology and treatment.
    The Journal of clinical psychiatry, 1983, Volume: 44, Issue:8 Pt 2

    Topics: Adult; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Female; Gal

1983
Endogenous anxiety: implications for nosology and treatment.
    The Journal of clinical psychiatry, 1983, Volume: 44, Issue:8 Pt 2

    Topics: Adult; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Female; Gal

1983
Delirium and seizures due to abrupt alprazolam withdrawal: case report.
    The Journal of clinical psychiatry, 1984, Volume: 45, Issue:1

    Topics: Aged; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Delirium; Half-Life; Huma

1984
Delirium and seizures due to abrupt alprazolam withdrawal: case report.
    The Journal of clinical psychiatry, 1984, Volume: 45, Issue:1

    Topics: Aged; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Delirium; Half-Life; Huma

1984
Alprazolam as treatment for a case of obsessive-compulsive disorder.
    The American journal of psychiatry, 1984, Volume: 141, Issue:5

    Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Humans; Male; Obsessive-

1984
Alprazolam as treatment for a case of obsessive-compulsive disorder.
    The American journal of psychiatry, 1984, Volume: 141, Issue:5

    Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Humans; Male; Obsessive-

1984
Emergence of hostility during alprazolam treatment.
    The American journal of psychiatry, 1984, Volume: 141, Issue:6

    Topics: Adult; Alprazolam; Anger; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Depressive Disord

1984
Emergence of hostility during alprazolam treatment.
    The American journal of psychiatry, 1984, Volume: 141, Issue:6

    Topics: Adult; Alprazolam; Anger; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Depressive Disord

1984
Treatment of panic attacks with alprazolam and propranolol.
    The American journal of psychiatry, 1984, Volume: 141, Issue:7

    Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Drug Synergism; Drug The

1984
Treatment of panic attacks with alprazolam and propranolol.
    The American journal of psychiatry, 1984, Volume: 141, Issue:7

    Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Drug Synergism; Drug The

1984
Alprazolam--a new triazolobenzodiazepine.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1984, Aug-25, Volume: 66, Issue:8

    Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Depressive Disorder; Drug Inter

1984
Alprazolam--a new triazolobenzodiazepine.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1984, Aug-25, Volume: 66, Issue:8

    Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Depressive Disorder; Drug Inter

1984
Successful treatment of endogenous depression with alprazolam in a patient with recent cardiac disease: case report.
    The Journal of clinical psychiatry, 1984, Volume: 45, Issue:11

    Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Coronary Disease; Depressive Di

1984
Successful treatment of endogenous depression with alprazolam in a patient with recent cardiac disease: case report.
    The Journal of clinical psychiatry, 1984, Volume: 45, Issue:11

    Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Coronary Disease; Depressive Di

1984
Delineation of anxiety and phobic disorders responsive to monoamine oxidase inhibitors: implications for classification.
    The Journal of clinical psychiatry, 1984, Volume: 45, Issue:7 Pt 2

    Topics: Alprazolam; Anxiety Disorders; Benzodiazepines; Bupropion; Depressive Disorder; Dexamethasone; Fear;

1984
Delineation of anxiety and phobic disorders responsive to monoamine oxidase inhibitors: implications for classification.
    The Journal of clinical psychiatry, 1984, Volume: 45, Issue:7 Pt 2

    Topics: Alprazolam; Anxiety Disorders; Benzodiazepines; Bupropion; Depressive Disorder; Dexamethasone; Fear;

1984
Panic attack syndrome.
    The Journal of pediatrics, 1984, Volume: 105, Issue:4

    Topics: Alprazolam; Antidepressive Agents; Anxiety Disorders; Benzodiazepines; Child; Fear; Humans; Hyperven

1984
Panic attack syndrome.
    The Journal of pediatrics, 1984, Volume: 105, Issue:4

    Topics: Alprazolam; Antidepressive Agents; Anxiety Disorders; Benzodiazepines; Child; Fear; Humans; Hyperven

1984
Psychopharmacologic treatment of panic disorder.
    Psychosomatics, 1984, Volume: 25, Issue:10 Suppl

    Topics: Alprazolam; Antidepressive Agents, Tricyclic; Anxiety Disorders; Benzodiazepines; Depressive Disorde

1984
Psychopharmacologic treatment of panic disorder.
    Psychosomatics, 1984, Volume: 25, Issue:10 Suppl

    Topics: Alprazolam; Antidepressive Agents, Tricyclic; Anxiety Disorders; Benzodiazepines; Depressive Disorde

1984
The use of alprazolam.
    The Australian and New Zealand journal of psychiatry, 1984, Volume: 18, Issue:2

    Topics: Adult; Alprazolam; Anxiety Disorders; Benzodiazepines; Fear; Humans; Male; Panic

1984
The use of alprazolam.
    The Australian and New Zealand journal of psychiatry, 1984, Volume: 18, Issue:2

    Topics: Adult; Alprazolam; Anxiety Disorders; Benzodiazepines; Fear; Humans; Male; Panic

1984
Serum dopamine-beta-hydroxylase activity in depression and anxiety.
    Biological psychiatry, 1984, Volume: 19, Issue:4

    Topics: Adult; Aged; Alprazolam; Anxiety; Anxiety Disorders; Benzodiazepines; Depression; Depressive Disorde

1984
Serum dopamine-beta-hydroxylase activity in depression and anxiety.
    Biological psychiatry, 1984, Volume: 19, Issue:4

    Topics: Adult; Aged; Alprazolam; Anxiety; Anxiety Disorders; Benzodiazepines; Depression; Depressive Disorde

1984
Clinical aspects of chronic use of alprazolam and lorazepam.
    The American journal of psychiatry, 1995, Volume: 152, Issue:8

    Topics: Alprazolam; Ambulatory Care; Anxiety Disorders; Depressive Disorder; Drug Administration Schedule; F

1995
Clinical aspects of chronic use of alprazolam and lorazepam.
    The American journal of psychiatry, 1995, Volume: 152, Issue:8

    Topics: Alprazolam; Ambulatory Care; Anxiety Disorders; Depressive Disorder; Drug Administration Schedule; F

1995
Upjohn responds to Consumer Reports letter.
    Journal of clinical psychopharmacology, 1994, Volume: 14, Issue:4

    Topics: Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Drug Industry; Drug Utilization; Humans; Pa

1994
Upjohn responds to Consumer Reports letter.
    Journal of clinical psychopharmacology, 1994, Volume: 14, Issue:4

    Topics: Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Drug Industry; Drug Utilization; Humans; Pa

1994
Response to "high anxiety".
    Journal of clinical psychopharmacology, 1994, Volume: 14, Issue:4

    Topics: Alprazolam; Anxiety Disorders; Dose-Response Relationship, Drug; Female; Humans; Panic Disorder; Ris

1994
Response to "high anxiety".
    Journal of clinical psychopharmacology, 1994, Volume: 14, Issue:4

    Topics: Alprazolam; Anxiety Disorders; Dose-Response Relationship, Drug; Female; Humans; Panic Disorder; Ris

1994
The effects of alprazolam on corticotropin-releasing factor neurons in the rat brain: implications for a role for CRF in the pathogenesis of anxiety disorders.
    Journal of psychiatric research, 1993, Volume: 27 Suppl 1

    Topics: Alprazolam; Animals; Anxiety Disorders; Brain; Corticotropin-Releasing Hormone; Hypothalamo-Hypophys

1993
The effects of alprazolam on corticotropin-releasing factor neurons in the rat brain: implications for a role for CRF in the pathogenesis of anxiety disorders.
    Journal of psychiatric research, 1993, Volume: 27 Suppl 1

    Topics: Alprazolam; Animals; Anxiety Disorders; Brain; Corticotropin-Releasing Hormone; Hypothalamo-Hypophys

1993
Anxiety sensitivity.
    The American journal of psychiatry, 1996, Volume: 153, Issue:8

    Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Benzodiazepines; Cognitive Behavioral Therapy; Combined

1996
Anxiety sensitivity.
    The American journal of psychiatry, 1996, Volume: 153, Issue:8

    Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Benzodiazepines; Cognitive Behavioral Therapy; Combined

1996
Clinical similarity and biological diversity in the response to alprazolam in patients with panic disorder and generalized anxiety disorder.
    Acta psychiatrica Scandinavica, 1995, Volume: 92, Issue:6

    Topics: Adrenocorticotropic Hormone; Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Catecholamin

1995
Clinical similarity and biological diversity in the response to alprazolam in patients with panic disorder and generalized anxiety disorder.
    Acta psychiatrica Scandinavica, 1995, Volume: 92, Issue:6

    Topics: Adrenocorticotropic Hormone; Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Catecholamin

1995
Alprazolam-induced hypomania.
    The Australian and New Zealand journal of psychiatry, 1996, Volume: 30, Issue:4

    Topics: Adult; Alprazolam; Anxiety Disorders; Bipolar Disorder; Depressive Disorder; Female; Humans; Psychia

1996
Alprazolam-induced hypomania.
    The Australian and New Zealand journal of psychiatry, 1996, Volume: 30, Issue:4

    Topics: Adult; Alprazolam; Anxiety Disorders; Bipolar Disorder; Depressive Disorder; Female; Humans; Psychia

1996
Graves'disease after the onset of panic disorder.
    Psychotherapy and psychosomatics, 1996, Volume: 65, Issue:5

    Topics: Alprazolam; Anxiety Disorders; Benzodiazepines; Female; Graves Disease; Humans; Hyperthyroidism; Lif

1996
Graves'disease after the onset of panic disorder.
    Psychotherapy and psychosomatics, 1996, Volume: 65, Issue:5

    Topics: Alprazolam; Anxiety Disorders; Benzodiazepines; Female; Graves Disease; Humans; Hyperthyroidism; Lif

1996
Method for assessing the duration of therapeutic action and milligram equivalence of anxiolytics.
    Anxiety, 1996, Volume: 2, Issue:1

    Topics: Adolescent; Adult; Aged; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Delayed-Ac

1996
Method for assessing the duration of therapeutic action and milligram equivalence of anxiolytics.
    Anxiety, 1996, Volume: 2, Issue:1

    Topics: Adolescent; Adult; Aged; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Delayed-Ac

1996
The realities of clonazepam discontinuation.
    Psychiatric services (Washington, D.C.), 1997, Volume: 48, Issue:7

    Topics: Alprazolam; Anxiety Disorders; Benzodiazepines; Clonazepam; Drug Administration Schedule; GABA Modul

1997
The realities of clonazepam discontinuation.
    Psychiatric services (Washington, D.C.), 1997, Volume: 48, Issue:7

    Topics: Alprazolam; Anxiety Disorders; Benzodiazepines; Clonazepam; Drug Administration Schedule; GABA Modul

1997
[Clinical effect of alprazolam and trazodone on bronchial asthmatics with anxiety disorder].
    Arerugi = [Allergy], 1997, Volume: 46, Issue:10

    Topics: Adult; Aged; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Asthma; Female; Humans; Male; Middl

1997
[Clinical effect of alprazolam and trazodone on bronchial asthmatics with anxiety disorder].
    Arerugi = [Allergy], 1997, Volume: 46, Issue:10

    Topics: Adult; Aged; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Asthma; Female; Humans; Male; Middl

1997
Gabapentin as a potential treatment for anxiety disorders.
    The American journal of psychiatry, 1998, Volume: 155, Issue:7

    Topics: Acetates; Adult; Alprazolam; Amines; Anticonvulsants; Anxiety Disorders; Cyclohexanecarboxylic Acids

1998
Gabapentin as a potential treatment for anxiety disorders.
    The American journal of psychiatry, 1998, Volume: 155, Issue:7

    Topics: Acetates; Adult; Alprazolam; Amines; Anticonvulsants; Anxiety Disorders; Cyclohexanecarboxylic Acids

1998
[Saliva level of free-3-methoxy-4-hydroxyphenylglycol in patients with anxiety disorders].
    Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology, 1999, Volume: 19, Issue:2

    Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Biomarkers; Female; Humans; Male; Methoxy

1999
[Saliva level of free-3-methoxy-4-hydroxyphenylglycol in patients with anxiety disorders].
    Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology, 1999, Volume: 19, Issue:2

    Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Biomarkers; Female; Humans; Male; Methoxy

1999
[Depression after age 50. Clinical case].
    L'Encephale, 2000, Volume: 26 Spec No 5

    Topics: Aged; Alprazolam; Anxiety Disorders; Depressive Disorder; Drug Therapy, Combination; Female; Humans;

2000
[Depression after age 50. Clinical case].
    L'Encephale, 2000, Volume: 26 Spec No 5

    Topics: Aged; Alprazolam; Anxiety Disorders; Depressive Disorder; Drug Therapy, Combination; Female; Humans;

2000
Role of dopaminergic and serotonergic systems on behavioral stimulatory effects of low-dose alprazolam and lorazepam.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2001, Volume: 11, Issue:1

    Topics: Alprazolam; Animals; Anti-Anxiety Agents; Anxiety Disorders; Dopamine; Dose-Response Relationship, D

2001
Role of dopaminergic and serotonergic systems on behavioral stimulatory effects of low-dose alprazolam and lorazepam.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2001, Volume: 11, Issue:1

    Topics: Alprazolam; Animals; Anti-Anxiety Agents; Anxiety Disorders; Dopamine; Dose-Response Relationship, D

2001
What are the issues surrounding long-term benzodiazepine treatment for generalized anxiety disorder.
    Journal of psychiatry & neuroscience : JPN, 1998, Volume: 23, Issue:1

    Topics: Adult; Alprazolam; Anxiety Disorders; Benzodiazepines; Diazepam; Drug Administration Schedule; Femal

1998
What are the issues surrounding long-term benzodiazepine treatment for generalized anxiety disorder.
    Journal of psychiatry & neuroscience : JPN, 1998, Volume: 23, Issue:1

    Topics: Adult; Alprazolam; Anxiety Disorders; Benzodiazepines; Diazepam; Drug Administration Schedule; Femal

1998
[A sudden relief from anxiety].
    Duodecim; laaketieteellinen aikakauskirja, 2000, Volume: 116, Issue:20

    Topics: Alprazolam; Anti-Anxiety Agents; Antifungal Agents; Anxiety Disorders; Drug Interactions; Humans; It

2000
[A sudden relief from anxiety].
    Duodecim; laaketieteellinen aikakauskirja, 2000, Volume: 116, Issue:20

    Topics: Alprazolam; Anti-Anxiety Agents; Antifungal Agents; Anxiety Disorders; Drug Interactions; Humans; It

2000
Seasonal panic disorder: a possible variant of seasonal affective disorder.
    The International journal of neuroscience, 1992, Volume: 62, Issue:3-4

    Topics: Adult; Alprazolam; Anxiety Disorders; Circadian Rhythm; Combined Modality Therapy; Depressive Disord

1992
Seasonal panic disorder: a possible variant of seasonal affective disorder.
    The International journal of neuroscience, 1992, Volume: 62, Issue:3-4

    Topics: Adult; Alprazolam; Anxiety Disorders; Circadian Rhythm; Combined Modality Therapy; Depressive Disord

1992
A prospective study of panic and anxiety in agoraphobia with panic disorder.
    The British journal of psychiatry : the journal of mental science, 1992, Volume: 160

    Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Arousal; Combined Modality Therapy; Desensitizati

1992
A prospective study of panic and anxiety in agoraphobia with panic disorder.
    The British journal of psychiatry : the journal of mental science, 1992, Volume: 160

    Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Arousal; Combined Modality Therapy; Desensitizati

1992
MDMA ("ecstasy") and panic disorder: induction by a single dose.
    Biological psychiatry, 1992, Nov-15, Volume: 32, Issue:10

    Topics: 3,4-Methylenedioxyamphetamine; Administration, Oral; Adult; Alprazolam; Anxiety Disorders; Arousal;

1992
MDMA ("ecstasy") and panic disorder: induction by a single dose.
    Biological psychiatry, 1992, Nov-15, Volume: 32, Issue:10

    Topics: 3,4-Methylenedioxyamphetamine; Administration, Oral; Adult; Alprazolam; Anxiety Disorders; Arousal;

1992
[Economic impact of integrating mental health in primary health care: apropos of a case].
    Atencion primaria, 1992, Volume: 9, Issue:2

    Topics: Adult; Alprazolam; Antidepressive Agents; Anxiety Disorders; Humans; Interprofessional Relations; Ma

1992
[Economic impact of integrating mental health in primary health care: apropos of a case].
    Atencion primaria, 1992, Volume: 9, Issue:2

    Topics: Adult; Alprazolam; Antidepressive Agents; Anxiety Disorders; Humans; Interprofessional Relations; Ma

1992
Panic disorder: strategies for long-term treatment.
    The Journal of clinical psychiatry, 1991, Volume: 52 Suppl

    Topics: Adolescent; Adult; Alprazolam; Anxiety Disorders; Diazepam; Female; Humans; Panic

1991
Panic disorder: strategies for long-term treatment.
    The Journal of clinical psychiatry, 1991, Volume: 52 Suppl

    Topics: Adolescent; Adult; Alprazolam; Anxiety Disorders; Diazepam; Female; Humans; Panic

1991
Prescription-event monitoring of 10,895 patients treated with alprazolam.
    The British journal of psychiatry : the journal of mental science, 1991, Volume: 158

    Topics: Adult; Aged; Alprazolam; Anxiety Disorders; Depressive Disorder; Drug Overdose; Female; Follow-Up St

1991
Prescription-event monitoring of 10,895 patients treated with alprazolam.
    The British journal of psychiatry : the journal of mental science, 1991, Volume: 158

    Topics: Adult; Aged; Alprazolam; Anxiety Disorders; Depressive Disorder; Drug Overdose; Female; Follow-Up St

1991
Exacerbation of panic disorder in a woman treated with trimethoprim-sulfamethoxazole.
    Journal of clinical psychopharmacology, 1991, Volume: 11, Issue:2

    Topics: Alprazolam; Anxiety Disorders; Drug Therapy, Combination; Female; Humans; Imipramine; Middle Aged; P

1991
Exacerbation of panic disorder in a woman treated with trimethoprim-sulfamethoxazole.
    Journal of clinical psychopharmacology, 1991, Volume: 11, Issue:2

    Topics: Alprazolam; Anxiety Disorders; Drug Therapy, Combination; Female; Humans; Imipramine; Middle Aged; P

1991
Switching from alprazolam to buspirone.
    Journal of clinical psychopharmacology, 1991, Volume: 11, Issue:3

    Topics: Alprazolam; Anxiety Disorders; Buspirone; Humans; Psychiatric Status Rating Scales; Substance Withdr

1991
Switching from alprazolam to buspirone.
    Journal of clinical psychopharmacology, 1991, Volume: 11, Issue:3

    Topics: Alprazolam; Anxiety Disorders; Buspirone; Humans; Psychiatric Status Rating Scales; Substance Withdr

1991
From the Food and Drug administration.
    JAMA, 1990, Dec-12, Volume: 264, Issue:22

    Topics: Alprazolam; Anxiety Disorders; Barium Sulfate; Communicable Disease Control; Dentists; Enema; Forms

1990
From the Food and Drug administration.
    JAMA, 1990, Dec-12, Volume: 264, Issue:22

    Topics: Alprazolam; Anxiety Disorders; Barium Sulfate; Communicable Disease Control; Dentists; Enema; Forms

1990
Longitudinal course of panic disorder: findings from the Massachusetts General Hospital Naturalistic Study.
    The Journal of clinical psychiatry, 1990, Volume: 51 Suppl A

    Topics: Alprazolam; Anxiety Disorders; Child, Preschool; Chronic Disease; Clonazepam; Cognitive Behavioral T

1990
Longitudinal course of panic disorder: findings from the Massachusetts General Hospital Naturalistic Study.
    The Journal of clinical psychiatry, 1990, Volume: 51 Suppl A

    Topics: Alprazolam; Anxiety Disorders; Child, Preschool; Chronic Disease; Clonazepam; Cognitive Behavioral T

1990
Treatment effects of alprazolam and imipramine: physiological versus subjective changes in patients with generalized anxiety disorder.
    Biological psychiatry, 1990, Nov-15, Volume: 28, Issue:10

    Topics: Adult; Alprazolam; Anxiety Disorders; Arousal; Electromyography; Epinephrine; Female; Heart Rate; Hu

1990
Treatment effects of alprazolam and imipramine: physiological versus subjective changes in patients with generalized anxiety disorder.
    Biological psychiatry, 1990, Nov-15, Volume: 28, Issue:10

    Topics: Adult; Alprazolam; Anxiety Disorders; Arousal; Electromyography; Epinephrine; Female; Heart Rate; Hu

1990
Switching patients from alprazolam to clonazepam.
    Hospital & community psychiatry, 1990, Volume: 41, Issue:12

    Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Clonazepam; Dose-Response Relationship, Drug; Drug Admin

1990
Switching patients from alprazolam to clonazepam.
    Hospital & community psychiatry, 1990, Volume: 41, Issue:12

    Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Clonazepam; Dose-Response Relationship, Drug; Drug Admin

1990
Reduction of gastrointestinal symptoms following treatment for panic disorder.
    Psychosomatics, 1990,Winter, Volume: 31, Issue:1

    Topics: Adult; Alprazolam; Anxiety Disorders; Colonic Diseases, Functional; Diazepam; Fear; Female; Gastroin

1990
Reduction of gastrointestinal symptoms following treatment for panic disorder.
    Psychosomatics, 1990,Winter, Volume: 31, Issue:1

    Topics: Adult; Alprazolam; Anxiety Disorders; Colonic Diseases, Functional; Diazepam; Fear; Female; Gastroin

1990
Plasma concentrations of melatonin in panic disorder.
    The American journal of psychiatry, 1990, Volume: 147, Issue:4

    Topics: Adult; Alprazolam; Anxiety Disorders; Circadian Rhythm; Fear; Female; Humans; Male; Melatonin; Panic

1990
Plasma concentrations of melatonin in panic disorder.
    The American journal of psychiatry, 1990, Volume: 147, Issue:4

    Topics: Adult; Alprazolam; Anxiety Disorders; Circadian Rhythm; Fear; Female; Humans; Male; Melatonin; Panic

1990
A patient with panic disorder eventuating in psychosis: nosology implications, Vol. 14, No. 3, September, 1989.
    Psychiatric journal of the University of Ottawa : Revue de psychiatrie de l'Universite d'Ottawa, 1990, Volume: 15, Issue:1

    Topics: Alprazolam; Anxiety Disorders; Fear; Female; Humans; Panic; Psychoses, Substance-Induced; Substance

1990
A patient with panic disorder eventuating in psychosis: nosology implications, Vol. 14, No. 3, September, 1989.
    Psychiatric journal of the University of Ottawa : Revue de psychiatrie de l'Universite d'Ottawa, 1990, Volume: 15, Issue:1

    Topics: Alprazolam; Anxiety Disorders; Fear; Female; Humans; Panic; Psychoses, Substance-Induced; Substance

1990
Severe withdrawal symptoms after discontinuation of alprazolam in eight patients with combat-induced posttraumatic stress disorder.
    The Journal of clinical psychiatry, 1990, Volume: 51, Issue:5

    Topics: Adult; Alprazolam; Anxiety Disorders; Benzodiazepines; Combat Disorders; Depressive Disorder; Homici

1990
Severe withdrawal symptoms after discontinuation of alprazolam in eight patients with combat-induced posttraumatic stress disorder.
    The Journal of clinical psychiatry, 1990, Volume: 51, Issue:5

    Topics: Adult; Alprazolam; Anxiety Disorders; Benzodiazepines; Combat Disorders; Depressive Disorder; Homici

1990
Mania in a panic disorder patient treated with fluoxetine.
    The American journal of psychiatry, 1990, Volume: 147, Issue:8

    Topics: Adult; Alprazolam; Anxiety Disorders; Bipolar Disorder; Fear; Fluoxetine; Humans; Male; Panic

1990
Mania in a panic disorder patient treated with fluoxetine.
    The American journal of psychiatry, 1990, Volume: 147, Issue:8

    Topics: Adult; Alprazolam; Anxiety Disorders; Bipolar Disorder; Fear; Fluoxetine; Humans; Male; Panic

1990
The relationship of panic disorder and its treatment outcome to 24-hour urinary MHPG levels.
    Psychiatry research, 1989, Volume: 30, Issue:1

    Topics: Adolescent; Adult; Aged; Alprazolam; Anxiety Disorders; Diazepam; Double-Blind Method; Fear; Glycols

1989
The relationship of panic disorder and its treatment outcome to 24-hour urinary MHPG levels.
    Psychiatry research, 1989, Volume: 30, Issue:1

    Topics: Adolescent; Adult; Aged; Alprazolam; Anxiety Disorders; Diazepam; Double-Blind Method; Fear; Glycols

1989
Buspirone and transvestic fetishism.
    The Journal of clinical psychiatry, 1989, Volume: 50, Issue:11

    Topics: Alprazolam; Anxiety Disorders; Buspirone; Fetishism, Psychiatric; Humans; Male; Paraphilic Disorders

1989
Buspirone and transvestic fetishism.
    The Journal of clinical psychiatry, 1989, Volume: 50, Issue:11

    Topics: Alprazolam; Anxiety Disorders; Buspirone; Fetishism, Psychiatric; Humans; Male; Paraphilic Disorders

1989
Imipramine and alprazolam treatment of lactate-induced acute endogenous distress in nonhuman primates.
    The American journal of psychiatry, 1989, Volume: 146, Issue:8

    Topics: Alprazolam; Animals; Anxiety Disorders; Behavior, Animal; Conditioning, Psychological; Fear; Homing

1989
Imipramine and alprazolam treatment of lactate-induced acute endogenous distress in nonhuman primates.
    The American journal of psychiatry, 1989, Volume: 146, Issue:8

    Topics: Alprazolam; Animals; Anxiety Disorders; Behavior, Animal; Conditioning, Psychological; Fear; Homing

1989
Symptoms and treatment responses of generalized anxiety disorder patients with high versus low levels of cardiovascular complaints.
    The American journal of psychiatry, 1989, Volume: 146, Issue:7

    Topics: Adult; Alprazolam; Anxiety Disorders; Female; Heart Diseases; Heart Rate; Humans; Imipramine; Male;

1989
Symptoms and treatment responses of generalized anxiety disorder patients with high versus low levels of cardiovascular complaints.
    The American journal of psychiatry, 1989, Volume: 146, Issue:7

    Topics: Adult; Alprazolam; Anxiety Disorders; Female; Heart Diseases; Heart Rate; Humans; Imipramine; Male;

1989
Panic disorder: diagnosis and treatment.
    Texas medicine, 1989, Volume: 85, Issue:8

    Topics: Alprazolam; Antidepressive Agents, Tricyclic; Anxiety Disorders; Fear; Humans; Monoamine Oxidase Inh

1989
Panic disorder: diagnosis and treatment.
    Texas medicine, 1989, Volume: 85, Issue:8

    Topics: Alprazolam; Antidepressive Agents, Tricyclic; Anxiety Disorders; Fear; Humans; Monoamine Oxidase Inh

1989
Pharmacological dissection of panic and depersonalization.
    The American journal of psychiatry, 1989, Volume: 146, Issue:3

    Topics: Adolescent; Alprazolam; Anxiety Disorders; Depersonalization; Fear; Female; Fluoxetine; Humans; Imip

1989
Pharmacological dissection of panic and depersonalization.
    The American journal of psychiatry, 1989, Volume: 146, Issue:3

    Topics: Adolescent; Alprazolam; Anxiety Disorders; Depersonalization; Fear; Female; Fluoxetine; Humans; Imip

1989
Depression in panic disorder and response to alprazolam therapy.
    Archives of general psychiatry, 1989, Volume: 46, Issue:11

    Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Depressive Disorder; Fear; Humans; Panic; Psychiatric St

1989
Depression in panic disorder and response to alprazolam therapy.
    Archives of general psychiatry, 1989, Volume: 46, Issue:11

    Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Depressive Disorder; Fear; Humans; Panic; Psychiatric St

1989
Clinical and medication outcome after short-term alprazolam and behavioral group treatment in panic disorder. 2.5 year naturalistic follow-up study.
    Archives of general psychiatry, 1989, Volume: 46, Issue:11

    Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Behavior Therapy; Combined Modality Therapy; Depr

1989
Clinical and medication outcome after short-term alprazolam and behavioral group treatment in panic disorder. 2.5 year naturalistic follow-up study.
    Archives of general psychiatry, 1989, Volume: 46, Issue:11

    Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Behavior Therapy; Combined Modality Therapy; Depr

1989
Action of imipramine and alprazolam in panic disorder.
    The American journal of psychiatry, 1988, Volume: 145, Issue:4

    Topics: Alprazolam; Anxiety Disorders; Fear; Humans; Imipramine; Panic; Receptors, Adrenergic; Receptors, GA

1988
Action of imipramine and alprazolam in panic disorder.
    The American journal of psychiatry, 1988, Volume: 145, Issue:4

    Topics: Alprazolam; Anxiety Disorders; Fear; Humans; Imipramine; Panic; Receptors, Adrenergic; Receptors, GA

1988
A withdrawal syndrome after abrupt discontinuation of alprazolam.
    The American journal of psychiatry, 1985, Volume: 142, Issue:1

    Topics: Adult; Agoraphobia; Akathisia, Drug-Induced; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Ben

1985
A withdrawal syndrome after abrupt discontinuation of alprazolam.
    The American journal of psychiatry, 1985, Volume: 142, Issue:1

    Topics: Adult; Agoraphobia; Akathisia, Drug-Induced; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Ben

1985
Noradrenergic function and the mechanism of action of antianxiety treatment. I. The effect of long-term alprazolam treatment.
    Archives of general psychiatry, 1985, Volume: 42, Issue:5

    Topics: Adult; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Blood Press

1985
Noradrenergic function and the mechanism of action of antianxiety treatment. I. The effect of long-term alprazolam treatment.
    Archives of general psychiatry, 1985, Volume: 42, Issue:5

    Topics: Adult; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Blood Press

1985
Three case reports of acute paroxysmal excitement associated with alprazolam treatment.
    The American journal of psychiatry, 1985, Volume: 142, Issue:7

    Topics: Acute Disease; Adult; Akathisia, Drug-Induced; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; B

1985
Three case reports of acute paroxysmal excitement associated with alprazolam treatment.
    The American journal of psychiatry, 1985, Volume: 142, Issue:7

    Topics: Acute Disease; Adult; Akathisia, Drug-Induced; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; B

1985
Seizures following the withdrawal of alprazolam.
    The Journal of nervous and mental disease, 1986, Volume: 174, Issue:1

    Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Female; Humans; Panic; S

1986
Seizures following the withdrawal of alprazolam.
    The Journal of nervous and mental disease, 1986, Volume: 174, Issue:1

    Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Female; Humans; Panic; S

1986
Preliminary evidence for the utility of carbamazepine in alprazolam withdrawal.
    The American journal of psychiatry, 1986, Volume: 143, Issue:2

    Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Carbamazepine; Female; H

1986
Preliminary evidence for the utility of carbamazepine in alprazolam withdrawal.
    The American journal of psychiatry, 1986, Volume: 143, Issue:2

    Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Carbamazepine; Female; H

1986
Alprazolam-induced ejaculatory inhibition.
    Journal of clinical psychopharmacology, 1986, Volume: 6, Issue:1

    Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Ejaculation; Humans; Male; Midd

1986
Alprazolam-induced ejaculatory inhibition.
    Journal of clinical psychopharmacology, 1986, Volume: 6, Issue:1

    Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Ejaculation; Humans; Male; Midd

1986
A case of alprazolam-related hepatitis.
    The American journal of psychiatry, 1986, Volume: 143, Issue:3

    Topics: Adult; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Chemical an

1986
A case of alprazolam-related hepatitis.
    The American journal of psychiatry, 1986, Volume: 143, Issue:3

    Topics: Adult; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Chemical an

1986
Alprazolam-induced manic episode in two patients with panic disorder.
    The American journal of psychiatry, 1986, Volume: 143, Issue:5

    Topics: Adult; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Bipolar Dis

1986
Alprazolam-induced manic episode in two patients with panic disorder.
    The American journal of psychiatry, 1986, Volume: 143, Issue:5

    Topics: Adult; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Bipolar Dis

1986
Postpanic anxiety disorder: diagnosis and treatment.
    Southern medical journal, 1986, Volume: 79, Issue:4

    Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Athletic Injuries; Benzodiazepines; Desen

1986
Postpanic anxiety disorder: diagnosis and treatment.
    Southern medical journal, 1986, Volume: 79, Issue:4

    Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Athletic Injuries; Benzodiazepines; Desen

1986
Alprazolam treatment for panic disorders.
    The Journal of clinical psychiatry, 1986, Volume: 47, Issue:6

    Topics: Adult; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Fear; Femal

1986
Alprazolam treatment for panic disorders.
    The Journal of clinical psychiatry, 1986, Volume: 47, Issue:6

    Topics: Adult; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Fear; Femal

1986
How antipanic drugs might work.
    The American journal of psychiatry, 1986, Volume: 143, Issue:7

    Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Fear; Female; Humans; Im

1986
How antipanic drugs might work.
    The American journal of psychiatry, 1986, Volume: 143, Issue:7

    Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Fear; Female; Humans; Im

1986
Biological markers in panic states: lactate-induced panic and mitral valve prolapse.
    Biological psychiatry, 1987, Volume: 22, Issue:3

    Topics: Adolescent; Adult; Aged; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Creatinine

1987
Biological markers in panic states: lactate-induced panic and mitral valve prolapse.
    Biological psychiatry, 1987, Volume: 22, Issue:3

    Topics: Adolescent; Adult; Aged; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Creatinine

1987
Adjunctive alprazolam for schizophrenia with panic anxiety: clinical observation and pathogenetic implications.
    The American journal of psychiatry, 1988, Volume: 145, Issue:6

    Topics: Adolescent; Adult; Alprazolam; Antipsychotic Agents; Anxiety Disorders; Dopamine; Drug Therapy, Comb

1988
Adjunctive alprazolam for schizophrenia with panic anxiety: clinical observation and pathogenetic implications.
    The American journal of psychiatry, 1988, Volume: 145, Issue:6

    Topics: Adolescent; Adult; Alprazolam; Antipsychotic Agents; Anxiety Disorders; Dopamine; Drug Therapy, Comb

1988
Alprazolam treatment of avoidant personality traits in social phobic patients.
    The Journal of clinical psychiatry, 1989, Volume: 50, Issue:3

    Topics: Adult; Alprazolam; Anxiety Disorders; Female; Humans; Male; Panic; Personality Disorders; Phobic Dis

1989
Alprazolam treatment of avoidant personality traits in social phobic patients.
    The Journal of clinical psychiatry, 1989, Volume: 50, Issue:3

    Topics: Adult; Alprazolam; Anxiety Disorders; Female; Humans; Male; Panic; Personality Disorders; Phobic Dis

1989
Clonazepam blockade of spontaneous and CO2 inhalation-provoked panic in a patient with panic disorder.
    The Journal of clinical psychiatry, 1986, Volume: 47, Issue:9

    Topics: Adult; Alprazolam; Anxiety Disorders; Benzodiazepines; Benzodiazepinones; Carbon Dioxide; Clonazepam

1986
Clonazepam blockade of spontaneous and CO2 inhalation-provoked panic in a patient with panic disorder.
    The Journal of clinical psychiatry, 1986, Volume: 47, Issue:9

    Topics: Adult; Alprazolam; Anxiety Disorders; Benzodiazepines; Benzodiazepinones; Carbon Dioxide; Clonazepam

1986
Alprazolam dependence in seven patients.
    The American journal of psychiatry, 1988, Volume: 145, Issue:5

    Topics: Adult; Alcoholism; Alprazolam; Anxiety Disorders; Depressive Disorder; Female; Humans; Male; Marijua

1988
Alprazolam dependence in seven patients.
    The American journal of psychiatry, 1988, Volume: 145, Issue:5

    Topics: Adult; Alcoholism; Alprazolam; Anxiety Disorders; Depressive Disorder; Female; Humans; Male; Marijua

1988
Alprazolam in the treatment of social phobia.
    The Journal of clinical psychiatry, 1988, Volume: 49, Issue:1

    Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Female; Humans; Male; Middle Aged; Panic; Phobic

1988
Alprazolam in the treatment of social phobia.
    The Journal of clinical psychiatry, 1988, Volume: 49, Issue:1

    Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Female; Humans; Male; Middle Aged; Panic; Phobic

1988
Alprazolam in the treatment of panic attack patients with and without major depression.
    The Journal of clinical psychiatry, 1988, Volume: 49, Issue:2

    Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Depressive Disorder; Fear; Female; Humans; Male;

1988
Alprazolam in the treatment of panic attack patients with and without major depression.
    The Journal of clinical psychiatry, 1988, Volume: 49, Issue:2

    Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Depressive Disorder; Fear; Female; Humans; Male;

1988
Alprazolam plus buspirone in treatment of anxiety.
    The American journal of psychiatry, 1988, Volume: 145, Issue:3

    Topics: Adult; Alprazolam; Ambulatory Care; Anxiety Disorders; Buspirone; Drug Therapy, Combination; Female;

1988
Alprazolam plus buspirone in treatment of anxiety.
    The American journal of psychiatry, 1988, Volume: 145, Issue:3

    Topics: Adult; Alprazolam; Ambulatory Care; Anxiety Disorders; Buspirone; Drug Therapy, Combination; Female;

1988
Alprazolam dependency: use of clonazepam for withdrawal.
    Southern medical journal, 1988, Volume: 81, Issue:7

    Topics: Adult; Alprazolam; Anxiety Disorders; Clonazepam; Humans; Hydrocortisone; Male; Substance Withdrawal

1988
Alprazolam dependency: use of clonazepam for withdrawal.
    Southern medical journal, 1988, Volume: 81, Issue:7

    Topics: Adult; Alprazolam; Anxiety Disorders; Clonazepam; Humans; Hydrocortisone; Male; Substance Withdrawal

1988
Patients with panic attacks and abnormal EEG results.
    The American journal of psychiatry, 1987, Volume: 144, Issue:4

    Topics: Adult; Alprazolam; Anxiety Disorders; Brain; Carbamazepine; Electroencephalography; Fear; Female; Hu

1987
Patients with panic attacks and abnormal EEG results.
    The American journal of psychiatry, 1987, Volume: 144, Issue:4

    Topics: Adult; Alprazolam; Anxiety Disorders; Brain; Carbamazepine; Electroencephalography; Fear; Female; Hu

1987
Schizophrenia, panic anxiety, and alprazolam.
    The American journal of psychiatry, 1987, Volume: 144, Issue:4

    Topics: Adult; Alprazolam; Anxiety Disorders; Drug Therapy, Combination; Fear; Haloperidol; Humans; Male; Pa

1987
Schizophrenia, panic anxiety, and alprazolam.
    The American journal of psychiatry, 1987, Volume: 144, Issue:4

    Topics: Adult; Alprazolam; Anxiety Disorders; Drug Therapy, Combination; Fear; Haloperidol; Humans; Male; Pa

1987
Emergence of depressive symptoms in patients receiving alprazolam for panic disorder.
    The American journal of psychiatry, 1987, Volume: 144, Issue:5

    Topics: Adult; Alprazolam; Anxiety Disorders; Depressive Disorder; Drug Therapy, Combination; Fear; Female;

1987
Emergence of depressive symptoms in patients receiving alprazolam for panic disorder.
    The American journal of psychiatry, 1987, Volume: 144, Issue:5

    Topics: Adult; Alprazolam; Anxiety Disorders; Depressive Disorder; Drug Therapy, Combination; Fear; Female;

1987
Combined alprazolam and phenelzine treatment of refractory depression with panic attacks.
    Biological psychiatry, 1987, Volume: 22, Issue:6

    Topics: Adult; Alprazolam; Anxiety Disorders; Depressive Disorder; Drug Therapy, Combination; Fear; Humans;

1987
Combined alprazolam and phenelzine treatment of refractory depression with panic attacks.
    Biological psychiatry, 1987, Volume: 22, Issue:6

    Topics: Adult; Alprazolam; Anxiety Disorders; Depressive Disorder; Drug Therapy, Combination; Fear; Humans;

1987
Alprazolam treatment for panic disorder.
    The Journal of clinical psychiatry, 1987, Volume: 48, Issue:7

    Topics: Adult; Alprazolam; Anxiety Disorders; Fear; Female; Humans; Male; Panic; Substance Withdrawal Syndro

1987
Alprazolam treatment for panic disorder.
    The Journal of clinical psychiatry, 1987, Volume: 48, Issue:7

    Topics: Adult; Alprazolam; Anxiety Disorders; Fear; Female; Humans; Male; Panic; Substance Withdrawal Syndro

1987
The alprazolam to clonazepam switch for the treatment of panic disorder.
    Journal of clinical psychopharmacology, 1987, Volume: 7, Issue:3

    Topics: Alprazolam; Anxiety Disorders; Clonazepam; Fear; Humans; Panic

1987
The alprazolam to clonazepam switch for the treatment of panic disorder.
    Journal of clinical psychopharmacology, 1987, Volume: 7, Issue:3

    Topics: Alprazolam; Anxiety Disorders; Clonazepam; Fear; Humans; Panic

1987
"Panic disorder" in schizophrenia.
    The Journal of nervous and mental disease, 1987, Volume: 175, Issue:10

    Topics: Adult; Alprazolam; Anxiety Disorders; Fear; Fluphenazine; Humans; Male; Panic; Schizophrenic Psychol

1987
"Panic disorder" in schizophrenia.
    The Journal of nervous and mental disease, 1987, Volume: 175, Issue:10

    Topics: Adult; Alprazolam; Anxiety Disorders; Fear; Fluphenazine; Humans; Male; Panic; Schizophrenic Psychol

1987
Synergistic action of alprazolam with tranylcypromine in drug-resistant atypical depression with panic attacks.
    Biological psychiatry, 1986, Volume: 21, Issue:5-6

    Topics: Alprazolam; Antidepressive Agents; Anxiety Disorders; Benzodiazepines; Depressive Disorder; Drug Res

1986
Synergistic action of alprazolam with tranylcypromine in drug-resistant atypical depression with panic attacks.
    Biological psychiatry, 1986, Volume: 21, Issue:5-6

    Topics: Alprazolam; Antidepressive Agents; Anxiety Disorders; Benzodiazepines; Depressive Disorder; Drug Res

1986
Treatment of panic disorder and agoraphobia with clonazepam.
    The Journal of clinical psychiatry, 1986, Volume: 47, Issue:5

    Topics: Adolescent; Adult; Aged; Agoraphobia; Alprazolam; Anxiety Disorders; Benzodiazepines; Benzodiazepino

1986
Treatment of panic disorder and agoraphobia with clonazepam.
    The Journal of clinical psychiatry, 1986, Volume: 47, Issue:5

    Topics: Adolescent; Adult; Aged; Agoraphobia; Alprazolam; Anxiety Disorders; Benzodiazepines; Benzodiazepino

1986
The effect of state anxiety on personality measurement.
    The American journal of psychiatry, 1986, Volume: 143, Issue:6

    Topics: Adult; Agoraphobia; Alprazolam; Anxiety; Anxiety Disorders; Benzodiazepines; Female; Humans; Male; P

1986
The effect of state anxiety on personality measurement.
    The American journal of psychiatry, 1986, Volume: 143, Issue:6

    Topics: Adult; Agoraphobia; Alprazolam; Anxiety; Anxiety Disorders; Benzodiazepines; Female; Humans; Male; P

1986
Successful use of clonazepam in patients with treatment-resistant panic disorder.
    The Journal of nervous and mental disease, 1986, Volume: 174, Issue:8

    Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Benzodiazepines; Benzodiazepinones; Clonazepam; D

1986
Successful use of clonazepam in patients with treatment-resistant panic disorder.
    The Journal of nervous and mental disease, 1986, Volume: 174, Issue:8

    Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Benzodiazepines; Benzodiazepinones; Clonazepam; D

1986
Can panic disorder present as irritable bowel syndrome?
    The Journal of clinical psychiatry, 1986, Volume: 47, Issue:9

    Topics: Adult; Alprazolam; Anxiety Disorders; Benzodiazepines; Colonic Diseases, Functional; Fear; Female; H

1986
Can panic disorder present as irritable bowel syndrome?
    The Journal of clinical psychiatry, 1986, Volume: 47, Issue:9

    Topics: Adult; Alprazolam; Anxiety Disorders; Benzodiazepines; Colonic Diseases, Functional; Fear; Female; H

1986
Agitated depression, alprazolam, and panic anxiety.
    The American journal of psychiatry, 1986, Volume: 143, Issue:9

    Topics: Adult; Aged; Alprazolam; Antidepressive Agents; Anxiety Disorders; Benzodiazepines; Depressive Disor

1986
Agitated depression, alprazolam, and panic anxiety.
    The American journal of psychiatry, 1986, Volume: 143, Issue:9

    Topics: Adult; Aged; Alprazolam; Antidepressive Agents; Anxiety Disorders; Benzodiazepines; Depressive Disor

1986
Sequential treatment of panic disorder with alprazolam and imipramine.
    The American journal of psychiatry, 1986, Volume: 143, Issue:12

    Topics: Alprazolam; Anxiety Disorders; Drug Administration Schedule; Drug Therapy, Combination; Fear; Humans

1986
Sequential treatment of panic disorder with alprazolam and imipramine.
    The American journal of psychiatry, 1986, Volume: 143, Issue:12

    Topics: Alprazolam; Anxiety Disorders; Drug Administration Schedule; Drug Therapy, Combination; Fear; Humans

1986
Carbamazepine, alprazolam withdrawal, and panic disorder.
    The American journal of psychiatry, 1987, Volume: 144, Issue:2

    Topics: Alprazolam; Anxiety Disorders; Carbamazepine; Fear; Humans; Panic; Substance Withdrawal Syndrome

1987
Carbamazepine, alprazolam withdrawal, and panic disorder.
    The American journal of psychiatry, 1987, Volume: 144, Issue:2

    Topics: Alprazolam; Anxiety Disorders; Carbamazepine; Fear; Humans; Panic; Substance Withdrawal Syndrome

1987
A case of alprazolam, but not lorazepam, inducing manic symptoms.
    The Journal of clinical psychiatry, 1987, Volume: 48, Issue:3

    Topics: Adult; Alprazolam; Anxiety Disorders; Bipolar Disorder; Female; Humans; Lorazepam; Panic

1987
A case of alprazolam, but not lorazepam, inducing manic symptoms.
    The Journal of clinical psychiatry, 1987, Volume: 48, Issue:3

    Topics: Adult; Alprazolam; Anxiety Disorders; Bipolar Disorder; Female; Humans; Lorazepam; Panic

1987
Discontinuation of alprazolam treatment in panic patients.
    The American journal of psychiatry, 1987, Volume: 144, Issue:3

    Topics: Acute Disease; Adult; Alprazolam; Anxiety Disorders; Dizziness; Fear; Female; Humans; Male; Middle A

1987
Discontinuation of alprazolam treatment in panic patients.
    The American journal of psychiatry, 1987, Volume: 144, Issue:3

    Topics: Acute Disease; Adult; Alprazolam; Anxiety Disorders; Dizziness; Fear; Female; Humans; Male; Middle A

1987
Globus hystericus and panic attacks.
    The American journal of psychiatry, 1987, Volume: 144, Issue:3

    Topics: Adult; Alprazolam; Anxiety Disorders; Conversion Disorder; Fear; Female; Humans; Panic

1987
Globus hystericus and panic attacks.
    The American journal of psychiatry, 1987, Volume: 144, Issue:3

    Topics: Adult; Alprazolam; Anxiety Disorders; Conversion Disorder; Fear; Female; Humans; Panic

1987
A proposed clinical approach to chronic and "resistant" depressions: evaluation and treatment.
    The Journal of clinical psychiatry, 1985, Volume: 46, Issue:10 Pt 2

    Topics: Alprazolam; Antidepressive Agents; Antidepressive Agents, Tricyclic; Anxiety Disorders; Benzodiazepi

1985
A proposed clinical approach to chronic and "resistant" depressions: evaluation and treatment.
    The Journal of clinical psychiatry, 1985, Volume: 46, Issue:10 Pt 2

    Topics: Alprazolam; Antidepressive Agents; Antidepressive Agents, Tricyclic; Anxiety Disorders; Benzodiazepi

1985
Thyroid indices in panic disorder.
    The Journal of clinical psychiatry, 1985, Volume: 46, Issue:10

    Topics: Adult; Alprazolam; Anxiety Disorders; Benzodiazepines; Fear; Female; Humans; Imipramine; Male; Middl

1985
Thyroid indices in panic disorder.
    The Journal of clinical psychiatry, 1985, Volume: 46, Issue:10

    Topics: Adult; Alprazolam; Anxiety Disorders; Benzodiazepines; Fear; Female; Humans; Imipramine; Male; Middl

1985
chemdatabank.com